| ENSG00000135253.9 |
Axitinib |
Bladder urothelial carcinoma |
0.00000241 |
Resistant |
| ENSG00000178977.3 |
Axitinib |
Bladder urothelial carcinoma |
0.004611537 |
Resistant |
| ENSG00000215241.3 |
Axitinib |
Bladder urothelial carcinoma |
0.042865435 |
Resistant |
| ENSG00000224086.3 |
Axitinib |
Bladder urothelial carcinoma |
0.017498188 |
Resistant |
| ENSG00000225611.1 |
Axitinib |
Bladder urothelial carcinoma |
0.01833432 |
Resistant |
| ENSG00000226416.1 |
Axitinib |
Bladder urothelial carcinoma |
0.036694832 |
Resistant |
| ENSG00000227674.1 |
Axitinib |
Bladder urothelial carcinoma |
0.032056923 |
Resistant |
| ENSG00000228150.1 |
Axitinib |
Bladder urothelial carcinoma |
0.01800496 |
Resistant |
| ENSG00000229896.2 |
Axitinib |
Bladder urothelial carcinoma |
0.019132485 |
Resistant |
| ENSG00000236760.1 |
Axitinib |
Bladder urothelial carcinoma |
0.047602519 |
Resistant |
| ENSG00000240859.1 |
Axitinib |
Bladder urothelial carcinoma |
0.004634754 |
Resistant |
| ENSG00000245281.2 |
Axitinib |
Bladder urothelial carcinoma |
0.021820249 |
Resistant |
| ENSG00000246225.2 |
Axitinib |
Bladder urothelial carcinoma |
0.012514036 |
Resistant |
| ENSG00000247134.2 |
Axitinib |
Bladder urothelial carcinoma |
0.026020236 |
Resistant |
| ENSG00000248238.1 |
Axitinib |
Bladder urothelial carcinoma |
0.035992282 |
Resistant |
| ENSG00000248810.1 |
Axitinib |
Bladder urothelial carcinoma |
0.048550778 |
Resistant |
| ENSG00000250874.1 |
Axitinib |
Bladder urothelial carcinoma |
0.005366618 |
Resistant |
| ENSG00000251611.1 |
Axitinib |
Bladder urothelial carcinoma |
0.03491786 |
Resistant |
| ENSG00000257894.1 |
Axitinib |
Bladder urothelial carcinoma |
0.023704857 |
Resistant |
| ENSG00000259319.1 |
Axitinib |
Bladder urothelial carcinoma |
0.036062825 |
Resistant |
| ENSG00000259438.1 |
Axitinib |
Bladder urothelial carcinoma |
0.000623364 |
Resistant |
| ENSG00000259694.1 |
Axitinib |
Bladder urothelial carcinoma |
0.043871546 |
Resistant |
| ENSG00000259942.1 |
Axitinib |
Bladder urothelial carcinoma |
0.04744622 |
Resistant |
| ENSG00000261314.1 |
Axitinib |
Bladder urothelial carcinoma |
0.019495108 |
Resistant |
| ENSG00000261434.1 |
Axitinib |
Bladder urothelial carcinoma |
0.004779062 |
Resistant |
| ENSG00000261662.1 |
Axitinib |
Bladder urothelial carcinoma |
0.032961526 |
Resistant |
| ENSG00000263063.1 |
Axitinib |
Bladder urothelial carcinoma |
0.024496208 |
Resistant |
| ENSG00000266824.1 |
Axitinib |
Bladder urothelial carcinoma |
0.045190551 |
Resistant |
| ENSG00000270265.1 |
Axitinib |
Bladder urothelial carcinoma |
0.02184152 |
Resistant |
| ENSG00000271826.1 |
Axitinib |
Bladder urothelial carcinoma |
0.034294096 |
Resistant |
| ENSG00000272403.1 |
Axitinib |
Bladder urothelial carcinoma |
0.018023841 |
Resistant |
| ENSG00000273406.1 |
Axitinib |
Bladder urothelial carcinoma |
0.011761394 |
Resistant |
| ENSG00000177112.3 |
Axitinib |
Breast invasive carcinoma |
0.020317858 |
Resistant |
| ENSG00000204832.5 |
Axitinib |
Breast invasive carcinoma |
0.038048094 |
Resistant |
| ENSG00000205444.2 |
Axitinib |
Breast invasive carcinoma |
0.045358238 |
Resistant |
| ENSG00000223813.2 |
Axitinib |
Breast invasive carcinoma |
0.042037813 |
Resistant |
| ENSG00000224078.8 |
Axitinib |
Breast invasive carcinoma |
0.007760388 |
Resistant |
| ENSG00000224822.1 |
Axitinib |
Breast invasive carcinoma |
0.026216224 |
Resistant |
| ENSG00000226091.3 |
Axitinib |
Breast invasive carcinoma |
0.036753904 |
Resistant |
| ENSG00000226330.1 |
Axitinib |
Breast invasive carcinoma |
0.040798431 |
Resistant |
| ENSG00000227375.1 |
Axitinib |
Breast invasive carcinoma |
0.040788384 |
Resistant |
| ENSG00000228043.1 |
Axitinib |
Breast invasive carcinoma |
0.030437689 |
Resistant |
| ENSG00000229980.4 |
Axitinib |
Breast invasive carcinoma |
0.02841672 |
Resistant |
| ENSG00000230113.1 |
Axitinib |
Breast invasive carcinoma |
0.038668207 |
Resistant |
| ENSG00000233517.1 |
Axitinib |
Breast invasive carcinoma |
0.045925883 |
Resistant |
| ENSG00000234261.1 |
Axitinib |
Breast invasive carcinoma |
0.046695568 |
Resistant |
| ENSG00000236617.2 |
Axitinib |
Breast invasive carcinoma |
0.038398669 |
Resistant |
| ENSG00000237166.1 |
Axitinib |
Breast invasive carcinoma |
0.002021119 |
Resistant |
| ENSG00000246263.2 |
Axitinib |
Breast invasive carcinoma |
0.037170094 |
Resistant |
| ENSG00000247199.3 |
Axitinib |
Breast invasive carcinoma |
0.037178362 |
Resistant |
| ENSG00000249042.1 |
Axitinib |
Breast invasive carcinoma |
0.0000989 |
Resistant |
| ENSG00000253477.1 |
Axitinib |
Breast invasive carcinoma |
0.03038182 |
Resistant |
| ENSG00000254286.1 |
Axitinib |
Breast invasive carcinoma |
0.021005401 |
Resistant |
| ENSG00000257151.1 |
Axitinib |
Breast invasive carcinoma |
0.03068006 |
Resistant |
| ENSG00000257647.1 |
Axitinib |
Breast invasive carcinoma |
0.019950814 |
Resistant |
| ENSG00000258701.1 |
Axitinib |
Breast invasive carcinoma |
0.045056783 |
Resistant |
| ENSG00000265743.1 |
Axitinib |
Breast invasive carcinoma |
0.032425961 |
Resistant |
| ENSG00000266921.1 |
Axitinib |
Breast invasive carcinoma |
0.048826529 |
Resistant |
| ENSG00000267288.1 |
Axitinib |
Breast invasive carcinoma |
0.04094234 |
Resistant |
| ENSG00000267667.1 |
Axitinib |
Breast invasive carcinoma |
0.032409757 |
Resistant |
| ENSG00000267751.1 |
Axitinib |
Breast invasive carcinoma |
0.039321028 |
Resistant |
| ENSG00000270246.2 |
Axitinib |
Breast invasive carcinoma |
0.006095969 |
Resistant |
| ENSG00000270704.2 |
Axitinib |
Breast invasive carcinoma |
0.047851436 |
Resistant |
| ENSG00000271147.3 |
Axitinib |
Breast invasive carcinoma |
0.012756213 |
Resistant |
| ENSG00000271347.1 |
Axitinib |
Breast invasive carcinoma |
0.027378744 |
Resistant |
| ENSG00000271830.1 |
Axitinib |
Breast invasive carcinoma |
0.025735711 |
Resistant |
| ENSG00000271835.1 |
Axitinib |
Breast invasive carcinoma |
0.045327786 |
Resistant |
| ENSG00000272312.1 |
Axitinib |
Breast invasive carcinoma |
0.02868912 |
Resistant |
| ENSG00000272384.1 |
Axitinib |
Breast invasive carcinoma |
0.040347874 |
Resistant |
| ENSG00000272465.1 |
Axitinib |
Breast invasive carcinoma |
0.012208197 |
Resistant |
| ENSG00000272721.1 |
Axitinib |
Breast invasive carcinoma |
0.026922665 |
Resistant |
| ENSG00000272846.1 |
Axitinib |
Breast invasive carcinoma |
0.00690453 |
Resistant |
| ENSG00000132832.5 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025490355 |
Resistant |
| ENSG00000203650.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017384286 |
Resistant |
| ENSG00000214184.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026962316 |
Resistant |
| ENSG00000214894.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041918613 |
Resistant |
| ENSG00000223695.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027734818 |
Resistant |
| ENSG00000224020.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042314103 |
Resistant |
| ENSG00000224939.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038572659 |
Resistant |
| ENSG00000225335.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045497485 |
Resistant |
| ENSG00000225778.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038340225 |
Resistant |
| ENSG00000227060.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030521707 |
Resistant |
| ENSG00000230337.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038178189 |
Resistant |
| ENSG00000230899.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023778135 |
Resistant |
| ENSG00000231441.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028074152 |
Resistant |
| ENSG00000231638.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.018930389 |
Resistant |
| ENSG00000231840.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006497978 |
Resistant |
| ENSG00000233237.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001030797 |
Resistant |
| ENSG00000234978.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028075976 |
Resistant |
| ENSG00000235770.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035995467 |
Resistant |
| ENSG00000235831.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041337555 |
Resistant |
| ENSG00000236098.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038833582 |
Resistant |
| ENSG00000236345.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015115855 |
Resistant |
| ENSG00000237721.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041504674 |
Resistant |
| ENSG00000240211.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037521018 |
Resistant |
| ENSG00000243176.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000621109 |
Resistant |
| ENSG00000254231.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032574295 |
Resistant |
| ENSG00000259062.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023594302 |
Resistant |
| ENSG00000261040.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009777992 |
Resistant |
| ENSG00000261644.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028318262 |
Resistant |
| ENSG00000261824.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023428116 |
Resistant |
| ENSG00000262185.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004026571 |
Resistant |
| ENSG00000266970.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004745427 |
Resistant |
| ENSG00000267308.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049704115 |
Resistant |
| ENSG00000270000.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048170925 |
Resistant |
| ENSG00000271849.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007407728 |
Resistant |
| ENSG00000272043.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026342974 |
Resistant |
| ENSG00000272275.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046984383 |
Resistant |
| ENSG00000178803.6 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003069674 |
Resistant |
| ENSG00000182310.8 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037680829 |
Resistant |
| ENSG00000188206.5 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010420421 |
Resistant |
| ENSG00000206573.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028085666 |
Resistant |
| ENSG00000213793.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01993461 |
Resistant |
| ENSG00000214851.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001910623 |
Resistant |
| ENSG00000215417.6 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018259599 |
Resistant |
| ENSG00000219665.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025969911 |
Resistant |
| ENSG00000223401.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034209827 |
Resistant |
| ENSG00000223598.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016368314 |
Resistant |
| ENSG00000223901.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029048744 |
Resistant |
| ENSG00000224565.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029564217 |
Resistant |
| ENSG00000225205.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008195723 |
Resistant |
| ENSG00000225836.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012362104 |
Resistant |
| ENSG00000226047.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016461132 |
Resistant |
| ENSG00000226381.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042302747 |
Resistant |
| ENSG00000227188.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04877078 |
Resistant |
| ENSG00000227492.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023418003 |
Resistant |
| ENSG00000227896.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000544466 |
Resistant |
| ENSG00000227963.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043099892 |
Resistant |
| ENSG00000228005.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004311872 |
Resistant |
| ENSG00000228079.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024170149 |
Resistant |
| ENSG00000228106.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046463596 |
Resistant |
| ENSG00000228302.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03823303 |
Resistant |
| ENSG00000229190.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042302384 |
Resistant |
| ENSG00000230633.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037275268 |
Resistant |
| ENSG00000231025.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017570165 |
Resistant |
| ENSG00000231050.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013468786 |
Resistant |
| ENSG00000231607.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005923329 |
Resistant |
| ENSG00000231789.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043970874 |
Resistant |
| ENSG00000231889.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00676808 |
Resistant |
| ENSG00000232116.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04033722 |
Resistant |
| ENSG00000232442.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012984769 |
Resistant |
| ENSG00000232648.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02704514 |
Resistant |
| ENSG00000232912.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016703809 |
Resistant |
| ENSG00000232936.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001745945 |
Resistant |
| ENSG00000233016.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04292033 |
Resistant |
| ENSG00000233108.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036330061 |
Resistant |
| ENSG00000233137.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020445458 |
Resistant |
| ENSG00000233296.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02120928 |
Resistant |
| ENSG00000233665.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023902507 |
Resistant |
| ENSG00000233834.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027977499 |
Resistant |
| ENSG00000233864.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00193812 |
Resistant |
| ENSG00000234171.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0383447 |
Resistant |
| ENSG00000234206.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003048958 |
Resistant |
| ENSG00000234741.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04967743 |
Resistant |
| ENSG00000234869.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013909695 |
Resistant |
| ENSG00000234884.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007287429 |
Resistant |
| ENSG00000235111.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006407881 |
Resistant |
| ENSG00000235204.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031271115 |
Resistant |
| ENSG00000235381.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005705782 |
Resistant |
| ENSG00000235590.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023802583 |
Resistant |
| ENSG00000235903.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010471925 |
Resistant |
| ENSG00000235908.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010412512 |
Resistant |
| ENSG00000236308.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026456958 |
Resistant |
| ENSG00000236519.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025562155 |
Resistant |
| ENSG00000236894.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010314565 |
Resistant |
| ENSG00000236901.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018655261 |
Resistant |
| ENSG00000236953.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048763992 |
Resistant |
| ENSG00000236991.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015108917 |
Resistant |
| ENSG00000237036.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01832019 |
Resistant |
| ENSG00000237328.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003866569 |
Resistant |
| ENSG00000237594.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044057571 |
Resistant |
| ENSG00000238121.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043882764 |
Resistant |
| ENSG00000238140.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008063164 |
Resistant |
| ENSG00000239480.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022582418 |
Resistant |
| ENSG00000240143.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024298277 |
Resistant |
| ENSG00000240373.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033765429 |
Resistant |
| ENSG00000240758.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016235971 |
Resistant |
| ENSG00000241280.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042413278 |
Resistant |
| ENSG00000244332.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030163375 |
Resistant |
| ENSG00000245213.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019973401 |
Resistant |
| ENSG00000245910.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022537946 |
Resistant |
| ENSG00000246323.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040013563 |
Resistant |
| ENSG00000246790.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016118614 |
Resistant |
| ENSG00000247092.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007073064 |
Resistant |
| ENSG00000247708.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014034645 |
Resistant |
| ENSG00000247982.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030376068 |
Resistant |
| ENSG00000248367.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000116093 |
Resistant |
| ENSG00000248559.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017170987 |
Resistant |
| ENSG00000248774.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014441317 |
Resistant |
| ENSG00000249241.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040907399 |
Resistant |
| ENSG00000249655.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04329047 |
Resistant |
| ENSG00000249685.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047436144 |
Resistant |
| ENSG00000250106.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009370858 |
Resistant |
| ENSG00000250295.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042486463 |
Resistant |
| ENSG00000250910.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030096704 |
Resistant |
| ENSG00000250988.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005886149 |
Resistant |
| ENSG00000251442.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013422813 |
Resistant |
| ENSG00000251538.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015780114 |
Resistant |
| ENSG00000251666.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021892474 |
Resistant |
| ENSG00000253174.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01338121 |
Resistant |
| ENSG00000253392.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023255078 |
Resistant |
| ENSG00000253837.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017082814 |
Resistant |
| ENSG00000254177.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002358857 |
Resistant |
| ENSG00000254281.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0483452 |
Resistant |
| ENSG00000254427.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024453657 |
Resistant |
| ENSG00000255135.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019525626 |
Resistant |
| ENSG00000255421.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000291434 |
Resistant |
| ENSG00000255449.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009069015 |
Resistant |
| ENSG00000255559.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007360417 |
Resistant |
| ENSG00000257815.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013285619 |
Resistant |
| ENSG00000258450.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02091075 |
Resistant |
| ENSG00000258704.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012250358 |
Resistant |
| ENSG00000259172.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00159981 |
Resistant |
| ENSG00000259238.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043541634 |
Resistant |
| ENSG00000259521.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023720248 |
Resistant |
| ENSG00000259583.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024734467 |
Resistant |
| ENSG00000259659.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022478906 |
Resistant |
| ENSG00000259768.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036931656 |
Resistant |
| ENSG00000259820.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007858578 |
Resistant |
| ENSG00000259994.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02984843 |
Resistant |
| ENSG00000260005.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031018087 |
Resistant |
| ENSG00000260177.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036467564 |
Resistant |
| ENSG00000260196.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008281798 |
Resistant |
| ENSG00000260278.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002996937 |
Resistant |
| ENSG00000260448.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035222659 |
Resistant |
| ENSG00000260495.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036785916 |
Resistant |
| ENSG00000260589.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042720977 |
Resistant |
| ENSG00000260664.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045730551 |
Resistant |
| ENSG00000260773.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036308905 |
Resistant |
| ENSG00000260924.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020965549 |
Resistant |
| ENSG00000261000.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012829264 |
Resistant |
| ENSG00000261135.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021391263 |
Resistant |
| ENSG00000261326.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015476827 |
Resistant |
| ENSG00000261420.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039807954 |
Resistant |
| ENSG00000261840.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022680391 |
Resistant |
| ENSG00000263884.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017414335 |
Resistant |
| ENSG00000263916.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003579524 |
Resistant |
| ENSG00000265342.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009829639 |
Resistant |
| ENSG00000265791.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023197292 |
Resistant |
| ENSG00000266289.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029119612 |
Resistant |
| ENSG00000266473.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013932894 |
Resistant |
| ENSG00000266926.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04063114 |
Resistant |
| ENSG00000267040.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007326397 |
Resistant |
| ENSG00000267152.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033624768 |
Resistant |
| ENSG00000267199.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03914493 |
Resistant |
| ENSG00000267274.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027581607 |
Resistant |
| ENSG00000267289.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043469972 |
Resistant |
| ENSG00000267419.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027363453 |
Resistant |
| ENSG00000267481.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04784025 |
Resistant |
| ENSG00000267787.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016346745 |
Resistant |
| ENSG00000267871.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012141344 |
Resistant |
| ENSG00000268649.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007287008 |
Resistant |
| ENSG00000268912.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048493762 |
Resistant |
| ENSG00000268970.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021444673 |
Resistant |
| ENSG00000269290.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009355788 |
Resistant |
| ENSG00000269293.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006172673 |
Resistant |
| ENSG00000269399.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030200138 |
Resistant |
| ENSG00000269487.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007327266 |
Resistant |
| ENSG00000269609.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004081818 |
Resistant |
| ENSG00000269942.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042435359 |
Resistant |
| ENSG00000269954.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025759398 |
Resistant |
| ENSG00000270062.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000189029 |
Resistant |
| ENSG00000270102.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029926217 |
Resistant |
| ENSG00000270116.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030480901 |
Resistant |
| ENSG00000270361.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042606242 |
Resistant |
| ENSG00000270605.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014622313 |
Resistant |
| ENSG00000271398.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016854323 |
Resistant |
| ENSG00000271856.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023976475 |
Resistant |
| ENSG00000272009.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027542848 |
Resistant |
| ENSG00000272053.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034171906 |
Resistant |
| ENSG00000272121.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035625424 |
Resistant |
| ENSG00000272192.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024054835 |
Resistant |
| ENSG00000272219.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031206863 |
Resistant |
| ENSG00000272254.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035312977 |
Resistant |
| ENSG00000272288.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01219541 |
Resistant |
| ENSG00000272689.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032216934 |
Resistant |
| ENSG00000272800.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029782399 |
Resistant |
| ENSG00000272853.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002343976 |
Resistant |
| ENSG00000272861.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01882077 |
Resistant |
| ENSG00000273162.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005520466 |
Resistant |
| ENSG00000273181.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014750868 |
Resistant |
| ENSG00000273188.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038719684 |
Resistant |
| ENSG00000273190.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015584029 |
Resistant |
| ENSG00000273384.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01498236 |
Resistant |
| ENSG00000273428.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01138897 |
Resistant |
| ENSG00000260441.1 |
Axitinib |
Esophageal cancer |
0.039154098 |
Resistant |
| ENSG00000272168.1 |
Axitinib |
Esophageal cancer |
0.003850482 |
Resistant |
| ENSG00000272379.1 |
Axitinib |
Esophageal cancer |
0.008064771 |
Resistant |
| ENSG00000188660.3 |
Axitinib |
Head and neck squamous cell carcinoma |
0.041802735 |
Resistant |
| ENSG00000189223.9 |
Axitinib |
Head and neck squamous cell carcinoma |
0.0060964 |
Resistant |
| ENSG00000225210.5 |
Axitinib |
Head and neck squamous cell carcinoma |
0.005994828 |
Resistant |
| ENSG00000229852.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.03231042 |
Resistant |
| ENSG00000237892.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.049062585 |
Resistant |
| ENSG00000242611.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.025404435 |
Resistant |
| ENSG00000246777.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.031916395 |
Resistant |
| ENSG00000257264.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.04732902 |
Resistant |
| ENSG00000261613.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.03441195 |
Resistant |
| ENSG00000266541.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.023994992 |
Resistant |
| ENSG00000269019.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.001774745 |
Resistant |
| ENSG00000272659.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.002317502 |
Resistant |
| ENSG00000153363.8 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022649371 |
Resistant |
| ENSG00000160336.10 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03934876 |
Resistant |
| ENSG00000178977.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.037317986 |
Resistant |
| ENSG00000179406.6 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000301203 |
Resistant |
| ENSG00000179743.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047701119 |
Resistant |
| ENSG00000179935.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008914196 |
Resistant |
| ENSG00000180846.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.032428058 |
Resistant |
| ENSG00000181798.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.025473939 |
Resistant |
| ENSG00000182109.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024076667 |
Resistant |
| ENSG00000184068.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023025708 |
Resistant |
| ENSG00000188185.7 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019965728 |
Resistant |
| ENSG00000189149.7 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049535811 |
Resistant |
| ENSG00000198468.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.033231797 |
Resistant |
| ENSG00000203865.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041168547 |
Resistant |
| ENSG00000204706.10 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044490179 |
Resistant |
| ENSG00000204802.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.020134211 |
Resistant |
| ENSG00000204837.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000329005 |
Resistant |
| ENSG00000212978.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.04409318 |
Resistant |
| ENSG00000213904.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.021552291 |
Resistant |
| ENSG00000215424.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013570092 |
Resistant |
| ENSG00000218018.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006521924 |
Resistant |
| ENSG00000220161.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.033023964 |
Resistant |
| ENSG00000223356.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.045415431 |
Resistant |
| ENSG00000223695.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000442159 |
Resistant |
| ENSG00000223711.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003585455 |
Resistant |
| ENSG00000223839.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.015256034 |
Resistant |
| ENSG00000223855.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049931513 |
Resistant |
| ENSG00000223901.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014133431 |
Resistant |
| ENSG00000223979.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047467443 |
Resistant |
| ENSG00000224023.6 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024673223 |
Resistant |
| ENSG00000224046.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041261992 |
Resistant |
| ENSG00000224079.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048072829 |
Resistant |
| ENSG00000224165.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047684861 |
Resistant |
| ENSG00000224281.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000293054 |
Resistant |
| ENSG00000224292.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001824393 |
Resistant |
| ENSG00000224660.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.045632681 |
Resistant |
| ENSG00000224699.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00187738 |
Resistant |
| ENSG00000224905.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008608981 |
Resistant |
| ENSG00000224969.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043246881 |
Resistant |
| ENSG00000225032.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043667004 |
Resistant |
| ENSG00000225075.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.045581302 |
Resistant |
| ENSG00000225194.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040732656 |
Resistant |
| ENSG00000225265.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044018428 |
Resistant |
| ENSG00000225335.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018417271 |
Resistant |
| ENSG00000225891.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014419044 |
Resistant |
| ENSG00000225945.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024418711 |
Resistant |
| ENSG00000225969.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.026766413 |
Resistant |
| ENSG00000225975.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.017989639 |
Resistant |
| ENSG00000226266.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.032452464 |
Resistant |
| ENSG00000226291.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024217069 |
Resistant |
| ENSG00000226330.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039210357 |
Resistant |
| ENSG00000226669.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014616627 |
Resistant |
| ENSG00000226853.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043714656 |
Resistant |
| ENSG00000226856.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036517472 |
Resistant |
| ENSG00000227068.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048569206 |
Resistant |
| ENSG00000227071.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046528571 |
Resistant |
| ENSG00000227083.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048436088 |
Resistant |
| ENSG00000227155.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024274843 |
Resistant |
| ENSG00000227237.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.026320965 |
Resistant |
| ENSG00000227354.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014293643 |
Resistant |
| ENSG00000227388.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0280095 |
Resistant |
| ENSG00000227409.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019117114 |
Resistant |
| ENSG00000227486.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.038100117 |
Resistant |
| ENSG00000227512.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013789875 |
Resistant |
| ENSG00000227527.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02871048 |
Resistant |
| ENSG00000227857.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022492213 |
Resistant |
| ENSG00000227963.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006401461 |
Resistant |
| ENSG00000228140.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003429026 |
Resistant |
| ENSG00000228315.7 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048760241 |
Resistant |
| ENSG00000228393.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02687126 |
Resistant |
| ENSG00000228395.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0000726 |
Resistant |
| ENSG00000228414.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028019839 |
Resistant |
| ENSG00000228436.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001880206 |
Resistant |
| ENSG00000228486.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.002928098 |
Resistant |
| ENSG00000228661.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.038854616 |
Resistant |
| ENSG00000228719.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018764291 |
Resistant |
| ENSG00000228857.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003292133 |
Resistant |
| ENSG00000228878.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008301858 |
Resistant |
| ENSG00000229043.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018652389 |
Resistant |
| ENSG00000229267.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016484202 |
Resistant |
| ENSG00000229311.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006322323 |
Resistant |
| ENSG00000229368.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.042742424 |
Resistant |
| ENSG00000229739.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.020801801 |
Resistant |
| ENSG00000229750.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.026708598 |
Resistant |
| ENSG00000229956.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019185834 |
Resistant |
| ENSG00000230091.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01477727 |
Resistant |
| ENSG00000230102.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047443437 |
Resistant |
| ENSG00000230303.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.034677258 |
Resistant |
| ENSG00000230337.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.033220499 |
Resistant |
| ENSG00000230424.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018052003 |
Resistant |
| ENSG00000230487.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019957023 |
Resistant |
| ENSG00000230565.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047443861 |
Resistant |
| ENSG00000230613.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01964094 |
Resistant |
| ENSG00000230736.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041442658 |
Resistant |
| ENSG00000230925.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.034224119 |
Resistant |
| ENSG00000230939.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040290185 |
Resistant |
| ENSG00000231024.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.027507295 |
Resistant |
| ENSG00000231028.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013566591 |
Resistant |
| ENSG00000231050.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004159311 |
Resistant |
| ENSG00000231154.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.032191852 |
Resistant |
| ENSG00000231290.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036795985 |
Resistant |
| ENSG00000231327.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039362428 |
Resistant |
| ENSG00000231393.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046404812 |
Resistant |
| ENSG00000231407.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006209025 |
Resistant |
| ENSG00000231507.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039670386 |
Resistant |
| ENSG00000231563.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000362543 |
Resistant |
| ENSG00000232063.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048131184 |
Resistant |
| ENSG00000232104.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.017211754 |
Resistant |
| ENSG00000232564.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049510792 |
Resistant |
| ENSG00000232586.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019620058 |
Resistant |
| ENSG00000232593.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036269548 |
Resistant |
| ENSG00000232645.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024552274 |
Resistant |
| ENSG00000232710.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044378296 |
Resistant |
| ENSG00000232827.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004933938 |
Resistant |
| ENSG00000232828.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.030688926 |
Resistant |
| ENSG00000232969.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049828304 |
Resistant |
| ENSG00000232995.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013426208 |
Resistant |
| ENSG00000233108.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003413342 |
Resistant |
| ENSG00000233178.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000908421 |
Resistant |
| ENSG00000233230.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.007760624 |
Resistant |
| ENSG00000233244.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.031225274 |
Resistant |
| ENSG00000233411.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041793405 |
Resistant |
| ENSG00000233621.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036747636 |
Resistant |
| ENSG00000233654.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029368787 |
Resistant |
| ENSG00000233799.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006245236 |
Resistant |
| ENSG00000233912.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024865532 |
Resistant |
| ENSG00000234019.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013400747 |
Resistant |
| ENSG00000234028.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024327961 |
Resistant |
| ENSG00000234183.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036562211 |
Resistant |
| ENSG00000234281.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013939818 |
Resistant |
| ENSG00000234393.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048857345 |
Resistant |
| ENSG00000234509.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044098435 |
Resistant |
| ENSG00000234663.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040477252 |
Resistant |
| ENSG00000234694.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039367403 |
Resistant |
| ENSG00000234771.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00153811 |
Resistant |
| ENSG00000234832.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008848801 |
Resistant |
| ENSG00000234884.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041507047 |
Resistant |
| ENSG00000234915.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.021449154 |
Resistant |
| ENSG00000234936.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03422871 |
Resistant |
| ENSG00000235262.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01767324 |
Resistant |
| ENSG00000235326.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028205377 |
Resistant |
| ENSG00000235527.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043170159 |
Resistant |
| ENSG00000235703.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009651598 |
Resistant |
| ENSG00000235897.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03509862 |
Resistant |
| ENSG00000236051.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03023497 |
Resistant |
| ENSG00000236095.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044245288 |
Resistant |
| ENSG00000236432.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.002548141 |
Resistant |
| ENSG00000236861.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.020664633 |
Resistant |
| ENSG00000237015.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.012210859 |
Resistant |
| ENSG00000237036.4 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02348437 |
Resistant |
| ENSG00000237037.5 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.015890269 |
Resistant |
| ENSG00000237133.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016171706 |
Resistant |
| ENSG00000237310.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009372734 |
Resistant |
| ENSG00000237328.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013467969 |
Resistant |
| ENSG00000237331.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.027943564 |
Resistant |
| ENSG00000237346.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.042458523 |
Resistant |
| ENSG00000237436.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03393308 |
Resistant |
| ENSG00000237461.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014130394 |
Resistant |
| ENSG00000237609.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047675109 |
Resistant |
| ENSG00000237756.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001600067 |
Resistant |
| ENSG00000237945.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02509 |
Resistant |
| ENSG00000238018.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.035574191 |
Resistant |
| ENSG00000238039.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.032497297 |
Resistant |
| ENSG00000238123.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036389996 |
Resistant |
| ENSG00000239213.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013011655 |
Resistant |
| ENSG00000239523.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.042181213 |
Resistant |
| ENSG00000239569.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.010014683 |
Resistant |
| ENSG00000239774.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028647496 |
Resistant |
| ENSG00000240137.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.035501395 |
Resistant |
| ENSG00000240618.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01506403 |
Resistant |
| ENSG00000240996.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043240426 |
Resistant |
| ENSG00000241288.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.034557624 |
Resistant |
| ENSG00000241316.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009637897 |
Resistant |
| ENSG00000241769.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000510588 |
Resistant |
| ENSG00000241770.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.002224127 |
Resistant |
| ENSG00000241933.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.042447799 |
Resistant |
| ENSG00000242553.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00717332 |
Resistant |
| ENSG00000242622.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028641224 |
Resistant |
| ENSG00000243176.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036231952 |
Resistant |
| ENSG00000243701.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.037784068 |
Resistant |
| ENSG00000244063.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00800368 |
Resistant |
| ENSG00000244268.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0473273 |
Resistant |
| ENSG00000244625.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006680375 |
Resistant |
| ENSG00000244952.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000892762 |
Resistant |
| ENSG00000245146.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019831214 |
Resistant |
| ENSG00000245534.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00000738 |
Resistant |
| ENSG00000245571.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.034561509 |
Resistant |
| ENSG00000245598.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019642421 |
Resistant |
| ENSG00000245614.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019282967 |
Resistant |
| ENSG00000245750.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046237623 |
Resistant |
| ENSG00000245857.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.027444963 |
Resistant |
| ENSG00000246067.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.012761264 |
Resistant |
| ENSG00000246225.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008738081 |
Resistant |
| ENSG00000246308.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013861824 |
Resistant |
| ENSG00000246859.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040167324 |
Resistant |
| ENSG00000247151.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039092793 |
Resistant |
| ENSG00000247271.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043829407 |
Resistant |
| ENSG00000247363.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02943787 |
Resistant |
| ENSG00000247679.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040854124 |
Resistant |
| ENSG00000247735.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000839172 |
Resistant |
| ENSG00000247828.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.007903116 |
Resistant |
| ENSG00000248240.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004630309 |
Resistant |
| ENSG00000248468.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039156611 |
Resistant |
| ENSG00000248554.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00088726 |
Resistant |
| ENSG00000248693.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039357627 |
Resistant |
| ENSG00000249492.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048257214 |
Resistant |
| ENSG00000249502.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016488622 |
Resistant |
| ENSG00000249894.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029986062 |
Resistant |
| ENSG00000250156.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029666247 |
Resistant |
| ENSG00000250938.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.034255479 |
Resistant |
| ENSG00000251131.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008376683 |
Resistant |
| ENSG00000251175.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001554462 |
Resistant |
| ENSG00000251417.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.033309819 |
Resistant |
| ENSG00000253263.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048791425 |
Resistant |
| ENSG00000253327.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.030898681 |
Resistant |
| ENSG00000253669.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01030846 |
Resistant |
| ENSG00000253730.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.020710805 |
Resistant |
| ENSG00000253773.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.012200594 |
Resistant |
| ENSG00000253837.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004128031 |
Resistant |
| ENSG00000253921.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03282639 |
Resistant |
| ENSG00000254207.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013894251 |
Resistant |
| ENSG00000254295.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02971583 |
Resistant |
| ENSG00000254450.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02804724 |
Resistant |
| ENSG00000254473.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019854293 |
Resistant |
| ENSG00000254900.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008961906 |
Resistant |
| ENSG00000255135.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028603425 |
Resistant |
| ENSG00000255142.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.011456516 |
Resistant |
| ENSG00000255160.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046541521 |
Resistant |
| ENSG00000255165.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.025284851 |
Resistant |
| ENSG00000255308.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048384068 |
Resistant |
| ENSG00000255355.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046000218 |
Resistant |
| ENSG00000255503.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013937766 |
Resistant |
| ENSG00000255568.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000855373 |
Resistant |
| ENSG00000255651.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041922611 |
Resistant |
| ENSG00000255669.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.006070397 |
Resistant |
| ENSG00000255966.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00721523 |
Resistant |
| ENSG00000256092.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022089125 |
Resistant |
| ENSG00000256249.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0385822 |
Resistant |
| ENSG00000256442.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.042372709 |
Resistant |
| ENSG00000256538.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.026048897 |
Resistant |
| ENSG00000256862.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049295199 |
Resistant |
| ENSG00000257135.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022165247 |
Resistant |
| ENSG00000257167.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047496999 |
Resistant |
| ENSG00000257556.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02779839 |
Resistant |
| ENSG00000258001.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00314714 |
Resistant |
| ENSG00000258458.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00144808 |
Resistant |
| ENSG00000258704.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001971756 |
Resistant |
| ENSG00000258730.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019519985 |
Resistant |
| ENSG00000258733.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.011150988 |
Resistant |
| ENSG00000259088.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.04603063 |
Resistant |
| ENSG00000259234.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001645338 |
Resistant |
| ENSG00000259274.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.041387563 |
Resistant |
| ENSG00000259327.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023753983 |
Resistant |
| ENSG00000259349.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03195511 |
Resistant |
| ENSG00000259595.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.017369838 |
Resistant |
| ENSG00000259775.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.030877559 |
Resistant |
| ENSG00000259826.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02614318 |
Resistant |
| ENSG00000259877.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047412433 |
Resistant |
| ENSG00000259926.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044486499 |
Resistant |
| ENSG00000260167.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023497028 |
Resistant |
| ENSG00000260219.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000716001 |
Resistant |
| ENSG00000260236.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000845449 |
Resistant |
| ENSG00000260288.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.033080117 |
Resistant |
| ENSG00000260336.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000308013 |
Resistant |
| ENSG00000260352.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.005622769 |
Resistant |
| ENSG00000260394.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028581475 |
Resistant |
| ENSG00000260475.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.007721279 |
Resistant |
| ENSG00000260493.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02964576 |
Resistant |
| ENSG00000260495.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009809796 |
Resistant |
| ENSG00000260498.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.010088003 |
Resistant |
| ENSG00000260619.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.010305834 |
Resistant |
| ENSG00000260641.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029340379 |
Resistant |
| ENSG00000260793.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047142604 |
Resistant |
| ENSG00000260796.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003306821 |
Resistant |
| ENSG00000260884.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.045834806 |
Resistant |
| ENSG00000260912.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046751603 |
Resistant |
| ENSG00000260936.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014852635 |
Resistant |
| ENSG00000260954.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046795985 |
Resistant |
| ENSG00000260988.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.011302041 |
Resistant |
| ENSG00000261043.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02087596 |
Resistant |
| ENSG00000261049.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.046647698 |
Resistant |
| ENSG00000261094.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009648333 |
Resistant |
| ENSG00000261118.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040909077 |
Resistant |
| ENSG00000261360.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003717025 |
Resistant |
| ENSG00000261386.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022430915 |
Resistant |
| ENSG00000261396.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.038221551 |
Resistant |
| ENSG00000261423.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00574583 |
Resistant |
| ENSG00000261673.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.015305657 |
Resistant |
| ENSG00000261695.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049182398 |
Resistant |
| ENSG00000261766.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018122963 |
Resistant |
| ENSG00000261839.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.032499354 |
Resistant |
| ENSG00000261840.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.003737834 |
Resistant |
| ENSG00000261879.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047362301 |
Resistant |
| ENSG00000262312.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039979172 |
Resistant |
| ENSG00000263004.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.010300517 |
Resistant |
| ENSG00000263072.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.021955202 |
Resistant |
| ENSG00000263370.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.042128009 |
Resistant |
| ENSG00000263412.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.002323803 |
Resistant |
| ENSG00000263531.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039570573 |
Resistant |
| ENSG00000263627.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.025323061 |
Resistant |
| ENSG00000263884.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.038061106 |
Resistant |
| ENSG00000264167.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016900299 |
Resistant |
| ENSG00000265943.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.005754877 |
Resistant |
| ENSG00000267010.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.030284225 |
Resistant |
| ENSG00000267018.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029001672 |
Resistant |
| ENSG00000267064.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.005665697 |
Resistant |
| ENSG00000267183.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.030381661 |
Resistant |
| ENSG00000267212.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000397913 |
Resistant |
| ENSG00000267231.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.045683905 |
Resistant |
| ENSG00000267344.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016562575 |
Resistant |
| ENSG00000267345.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018443073 |
Resistant |
| ENSG00000267348.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028202928 |
Resistant |
| ENSG00000267390.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.007424755 |
Resistant |
| ENSG00000267565.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.035850991 |
Resistant |
| ENSG00000267651.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022034517 |
Resistant |
| ENSG00000267705.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.020999024 |
Resistant |
| ENSG00000267834.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000173178 |
Resistant |
| ENSG00000267898.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.005254512 |
Resistant |
| ENSG00000267939.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.005780885 |
Resistant |
| ENSG00000268095.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004349639 |
Resistant |
| ENSG00000268401.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013018635 |
Resistant |
| ENSG00000268516.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004150943 |
Resistant |
| ENSG00000268947.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.027978624 |
Resistant |
| ENSG00000268970.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.037378176 |
Resistant |
| ENSG00000269220.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029012009 |
Resistant |
| ENSG00000269290.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.008087289 |
Resistant |
| ENSG00000269534.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019301616 |
Resistant |
| ENSG00000269961.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049667176 |
Resistant |
| ENSG00000270006.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.031853299 |
Resistant |
| ENSG00000270012.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01719107 |
Resistant |
| ENSG00000270019.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.021342421 |
Resistant |
| ENSG00000270049.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004940536 |
Resistant |
| ENSG00000270061.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.038469115 |
Resistant |
| ENSG00000270062.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01102124 |
Resistant |
| ENSG00000270068.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.03084648 |
Resistant |
| ENSG00000270095.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.045737456 |
Resistant |
| ENSG00000270130.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.027689338 |
Resistant |
| ENSG00000270820.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.002102327 |
Resistant |
| ENSG00000270996.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028604899 |
Resistant |
| ENSG00000271151.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.002094159 |
Resistant |
| ENSG00000271172.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018251868 |
Resistant |
| ENSG00000271265.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047961905 |
Resistant |
| ENSG00000271646.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048907872 |
Resistant |
| ENSG00000271737.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.021080952 |
Resistant |
| ENSG00000271820.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047049929 |
Resistant |
| ENSG00000271824.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0449309 |
Resistant |
| ENSG00000272092.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0142682 |
Resistant |
| ENSG00000272192.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02927026 |
Resistant |
| ENSG00000272211.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048086084 |
Resistant |
| ENSG00000272217.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.019262046 |
Resistant |
| ENSG00000272368.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022695032 |
Resistant |
| ENSG00000272369.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023457047 |
Resistant |
| ENSG00000272374.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.024192238 |
Resistant |
| ENSG00000272377.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.017141056 |
Resistant |
| ENSG00000272382.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0492371 |
Resistant |
| ENSG00000272524.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.043677487 |
Resistant |
| ENSG00000272562.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.022741277 |
Resistant |
| ENSG00000272662.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009996831 |
Resistant |
| ENSG00000272669.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009266809 |
Resistant |
| ENSG00000272682.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.029348317 |
Resistant |
| ENSG00000272696.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.027764535 |
Resistant |
| ENSG00000272721.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.013966091 |
Resistant |
| ENSG00000272735.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.033041132 |
Resistant |
| ENSG00000272870.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.044948053 |
Resistant |
| ENSG00000273000.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049046033 |
Resistant |
| ENSG00000273001.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.047261336 |
Resistant |
| ENSG00000273002.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.014048399 |
Resistant |
| ENSG00000273004.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000277283 |
Resistant |
| ENSG00000273026.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.004550869 |
Resistant |
| ENSG00000273061.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.00808171 |
Resistant |
| ENSG00000273175.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.038074771 |
Resistant |
| ENSG00000273243.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.048086376 |
Resistant |
| ENSG00000273308.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023188942 |
Resistant |
| ENSG00000273342.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.039498264 |
Resistant |
| ENSG00000273424.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.04138752 |
Resistant |
| ENSG00000273448.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.009879173 |
Resistant |
| ENSG00000273486.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.007353658 |
Resistant |
| ENSG00000136315.3 |
Axitinib |
Brain lower grade glioma |
0.014932918 |
Resistant |
| ENSG00000174171.4 |
Axitinib |
Brain lower grade glioma |
0.012145096 |
Resistant |
| ENSG00000175772.10 |
Axitinib |
Brain lower grade glioma |
0.032928155 |
Resistant |
| ENSG00000189223.9 |
Axitinib |
Brain lower grade glioma |
0.010054101 |
Resistant |
| ENSG00000203588.3 |
Axitinib |
Brain lower grade glioma |
0.026658507 |
Resistant |
| ENSG00000214955.5 |
Axitinib |
Brain lower grade glioma |
0.007245882 |
Resistant |
| ENSG00000215039.2 |
Axitinib |
Brain lower grade glioma |
0.032815469 |
Resistant |
| ENSG00000223697.2 |
Axitinib |
Brain lower grade glioma |
0.040665934 |
Resistant |
| ENSG00000223701.3 |
Axitinib |
Brain lower grade glioma |
0.03692072 |
Resistant |
| ENSG00000223711.1 |
Axitinib |
Brain lower grade glioma |
0.048579226 |
Resistant |
| ENSG00000223749.3 |
Axitinib |
Brain lower grade glioma |
0.0235465 |
Resistant |
| ENSG00000224609.2 |
Axitinib |
Brain lower grade glioma |
0.006544611 |
Resistant |
| ENSG00000224660.1 |
Axitinib |
Brain lower grade glioma |
0.024360756 |
Resistant |
| ENSG00000224687.1 |
Axitinib |
Brain lower grade glioma |
0.018096584 |
Resistant |
| ENSG00000224715.1 |
Axitinib |
Brain lower grade glioma |
0.025415863 |
Resistant |
| ENSG00000225216.2 |
Axitinib |
Brain lower grade glioma |
0.029756146 |
Resistant |
| ENSG00000225839.2 |
Axitinib |
Brain lower grade glioma |
0.021986065 |
Resistant |
| ENSG00000226053.1 |
Axitinib |
Brain lower grade glioma |
0.037599356 |
Resistant |
| ENSG00000226816.2 |
Axitinib |
Brain lower grade glioma |
0.038111139 |
Resistant |
| ENSG00000227456.3 |
Axitinib |
Brain lower grade glioma |
0.016217318 |
Resistant |
| ENSG00000227740.1 |
Axitinib |
Brain lower grade glioma |
0.005054532 |
Resistant |
| ENSG00000227938.1 |
Axitinib |
Brain lower grade glioma |
0.035365221 |
Resistant |
| ENSG00000228242.3 |
Axitinib |
Brain lower grade glioma |
0.028966218 |
Resistant |
| ENSG00000228372.3 |
Axitinib |
Brain lower grade glioma |
0.017787139 |
Resistant |
| ENSG00000228386.2 |
Axitinib |
Brain lower grade glioma |
0.022269759 |
Resistant |
| ENSG00000228527.1 |
Axitinib |
Brain lower grade glioma |
0.02721572 |
Resistant |
| ENSG00000228679.1 |
Axitinib |
Brain lower grade glioma |
0.014844075 |
Resistant |
| ENSG00000228794.4 |
Axitinib |
Brain lower grade glioma |
0.028274279 |
Resistant |
| ENSG00000230753.1 |
Axitinib |
Brain lower grade glioma |
0.036287552 |
Resistant |
| ENSG00000231566.1 |
Axitinib |
Brain lower grade glioma |
0.030550636 |
Resistant |
| ENSG00000232224.1 |
Axitinib |
Brain lower grade glioma |
0.030994181 |
Resistant |
| ENSG00000232656.3 |
Axitinib |
Brain lower grade glioma |
0.003076282 |
Resistant |
| ENSG00000232696.1 |
Axitinib |
Brain lower grade glioma |
0.012653899 |
Resistant |
| ENSG00000232874.1 |
Axitinib |
Brain lower grade glioma |
0.043988025 |
Resistant |
| ENSG00000233237.2 |
Axitinib |
Brain lower grade glioma |
0.043294244 |
Resistant |
| ENSG00000233547.1 |
Axitinib |
Brain lower grade glioma |
0.019169259 |
Resistant |
| ENSG00000233643.2 |
Axitinib |
Brain lower grade glioma |
0.012470472 |
Resistant |
| ENSG00000234062.3 |
Axitinib |
Brain lower grade glioma |
0.011592557 |
Resistant |
| ENSG00000234149.1 |
Axitinib |
Brain lower grade glioma |
0.046090245 |
Resistant |
| ENSG00000234181.1 |
Axitinib |
Brain lower grade glioma |
0.044339135 |
Resistant |
| ENSG00000234571.1 |
Axitinib |
Brain lower grade glioma |
0.039654833 |
Resistant |
| ENSG00000235802.1 |
Axitinib |
Brain lower grade glioma |
0.01979064 |
Resistant |
| ENSG00000236915.1 |
Axitinib |
Brain lower grade glioma |
0.028702744 |
Resistant |
| ENSG00000237481.1 |
Axitinib |
Brain lower grade glioma |
0.048322492 |
Resistant |
| ENSG00000237756.1 |
Axitinib |
Brain lower grade glioma |
0.023197211 |
Resistant |
| ENSG00000237927.1 |
Axitinib |
Brain lower grade glioma |
0.016959936 |
Resistant |
| ENSG00000237928.1 |
Axitinib |
Brain lower grade glioma |
0.031034651 |
Resistant |
| ENSG00000238210.2 |
Axitinib |
Brain lower grade glioma |
0.020586453 |
Resistant |
| ENSG00000238279.1 |
Axitinib |
Brain lower grade glioma |
0.001452616 |
Resistant |
| ENSG00000239653.1 |
Axitinib |
Brain lower grade glioma |
0.002001395 |
Resistant |
| ENSG00000241219.1 |
Axitinib |
Brain lower grade glioma |
0.003692352 |
Resistant |
| ENSG00000241572.1 |
Axitinib |
Brain lower grade glioma |
0.014821248 |
Resistant |
| ENSG00000241818.1 |
Axitinib |
Brain lower grade glioma |
0.049944767 |
Resistant |
| ENSG00000242190.1 |
Axitinib |
Brain lower grade glioma |
0.012826026 |
Resistant |
| ENSG00000244757.1 |
Axitinib |
Brain lower grade glioma |
0.040323644 |
Resistant |
| ENSG00000245311.2 |
Axitinib |
Brain lower grade glioma |
0.020459354 |
Resistant |
| ENSG00000246740.2 |
Axitinib |
Brain lower grade glioma |
0.041399674 |
Resistant |
| ENSG00000247081.3 |
Axitinib |
Brain lower grade glioma |
0.012707477 |
Resistant |
| ENSG00000247982.2 |
Axitinib |
Brain lower grade glioma |
0.01109243 |
Resistant |
| ENSG00000248019.2 |
Axitinib |
Brain lower grade glioma |
0.038116306 |
Resistant |
| ENSG00000248356.1 |
Axitinib |
Brain lower grade glioma |
0.032464746 |
Resistant |
| ENSG00000248664.1 |
Axitinib |
Brain lower grade glioma |
0.013571639 |
Resistant |
| ENSG00000248714.2 |
Axitinib |
Brain lower grade glioma |
0.000590572 |
Resistant |
| ENSG00000249406.1 |
Axitinib |
Brain lower grade glioma |
0.045283386 |
Resistant |
| ENSG00000249685.1 |
Axitinib |
Brain lower grade glioma |
0.042356301 |
Resistant |
| ENSG00000249791.1 |
Axitinib |
Brain lower grade glioma |
0.011059905 |
Resistant |
| ENSG00000249835.2 |
Axitinib |
Brain lower grade glioma |
0.030795319 |
Resistant |
| ENSG00000249898.3 |
Axitinib |
Brain lower grade glioma |
0.036892459 |
Resistant |
| ENSG00000250081.1 |
Axitinib |
Brain lower grade glioma |
0.020408357 |
Resistant |
| ENSG00000250280.2 |
Axitinib |
Brain lower grade glioma |
0.040917232 |
Resistant |
| ENSG00000250692.1 |
Axitinib |
Brain lower grade glioma |
0.045354528 |
Resistant |
| ENSG00000251085.1 |
Axitinib |
Brain lower grade glioma |
0.019933264 |
Resistant |
| ENSG00000251221.1 |
Axitinib |
Brain lower grade glioma |
0.003533584 |
Resistant |
| ENSG00000251379.1 |
Axitinib |
Brain lower grade glioma |
0.042749351 |
Resistant |
| ENSG00000251455.1 |
Axitinib |
Brain lower grade glioma |
0.045712575 |
Resistant |
| ENSG00000253167.1 |
Axitinib |
Brain lower grade glioma |
0.040113964 |
Resistant |
| ENSG00000253802.1 |
Axitinib |
Brain lower grade glioma |
0.028353561 |
Resistant |
| ENSG00000253848.1 |
Axitinib |
Brain lower grade glioma |
0.02052011 |
Resistant |
| ENSG00000254109.1 |
Axitinib |
Brain lower grade glioma |
0.038167592 |
Resistant |
| ENSG00000254180.1 |
Axitinib |
Brain lower grade glioma |
0.011601032 |
Resistant |
| ENSG00000254731.1 |
Axitinib |
Brain lower grade glioma |
0.042149268 |
Resistant |
| ENSG00000255045.1 |
Axitinib |
Brain lower grade glioma |
0.042124608 |
Resistant |
| ENSG00000255164.1 |
Axitinib |
Brain lower grade glioma |
0.009558811 |
Resistant |
| ENSG00000255202.1 |
Axitinib |
Brain lower grade glioma |
0.042629068 |
Resistant |
| ENSG00000255893.1 |
Axitinib |
Brain lower grade glioma |
0.012865358 |
Resistant |
| ENSG00000256742.1 |
Axitinib |
Brain lower grade glioma |
0.009151587 |
Resistant |
| ENSG00000257202.1 |
Axitinib |
Brain lower grade glioma |
0.014373532 |
Resistant |
| ENSG00000257322.1 |
Axitinib |
Brain lower grade glioma |
0.002048661 |
Resistant |
| ENSG00000257354.1 |
Axitinib |
Brain lower grade glioma |
0.004003434 |
Resistant |
| ENSG00000258086.1 |
Axitinib |
Brain lower grade glioma |
0.048824158 |
Resistant |
| ENSG00000258378.1 |
Axitinib |
Brain lower grade glioma |
0.008068246 |
Resistant |
| ENSG00000258441.1 |
Axitinib |
Brain lower grade glioma |
0.042640387 |
Resistant |
| ENSG00000258569.1 |
Axitinib |
Brain lower grade glioma |
0.048185058 |
Resistant |
| ENSG00000258766.1 |
Axitinib |
Brain lower grade glioma |
0.006934882 |
Resistant |
| ENSG00000259026.1 |
Axitinib |
Brain lower grade glioma |
0.021539029 |
Resistant |
| ENSG00000259287.1 |
Axitinib |
Brain lower grade glioma |
0.026666295 |
Resistant |
| ENSG00000259398.1 |
Axitinib |
Brain lower grade glioma |
0.000907555 |
Resistant |
| ENSG00000259408.1 |
Axitinib |
Brain lower grade glioma |
0.028558069 |
Resistant |
| ENSG00000259437.1 |
Axitinib |
Brain lower grade glioma |
0.02062043 |
Resistant |
| ENSG00000259515.1 |
Axitinib |
Brain lower grade glioma |
0.013958068 |
Resistant |
| ENSG00000259631.1 |
Axitinib |
Brain lower grade glioma |
0.047011941 |
Resistant |
| ENSG00000259656.1 |
Axitinib |
Brain lower grade glioma |
0.047403494 |
Resistant |
| ENSG00000259709.1 |
Axitinib |
Brain lower grade glioma |
0.029456622 |
Resistant |
| ENSG00000259732.1 |
Axitinib |
Brain lower grade glioma |
0.015231461 |
Resistant |
| ENSG00000259744.1 |
Axitinib |
Brain lower grade glioma |
0.048900007 |
Resistant |
| ENSG00000259783.1 |
Axitinib |
Brain lower grade glioma |
0.031804935 |
Resistant |
| ENSG00000259883.1 |
Axitinib |
Brain lower grade glioma |
0.026683753 |
Resistant |
| ENSG00000259888.1 |
Axitinib |
Brain lower grade glioma |
0.040705076 |
Resistant |
| ENSG00000259899.1 |
Axitinib |
Brain lower grade glioma |
0.041448474 |
Resistant |
| ENSG00000259921.1 |
Axitinib |
Brain lower grade glioma |
0.008741695 |
Resistant |
| ENSG00000260060.1 |
Axitinib |
Brain lower grade glioma |
0.037128958 |
Resistant |
| ENSG00000260278.1 |
Axitinib |
Brain lower grade glioma |
0.020605628 |
Resistant |
| ENSG00000260368.1 |
Axitinib |
Brain lower grade glioma |
0.00622853 |
Resistant |
| ENSG00000260392.1 |
Axitinib |
Brain lower grade glioma |
0.036877995 |
Resistant |
| ENSG00000260648.2 |
Axitinib |
Brain lower grade glioma |
0.010586818 |
Resistant |
| ENSG00000260910.1 |
Axitinib |
Brain lower grade glioma |
0.038198559 |
Resistant |
| ENSG00000260938.1 |
Axitinib |
Brain lower grade glioma |
0.017399775 |
Resistant |
| ENSG00000260986.1 |
Axitinib |
Brain lower grade glioma |
0.043193066 |
Resistant |
| ENSG00000261083.1 |
Axitinib |
Brain lower grade glioma |
0.041101493 |
Resistant |
| ENSG00000261295.1 |
Axitinib |
Brain lower grade glioma |
0.047014074 |
Resistant |
| ENSG00000261305.1 |
Axitinib |
Brain lower grade glioma |
0.022831068 |
Resistant |
| ENSG00000261469.1 |
Axitinib |
Brain lower grade glioma |
0.00352383 |
Resistant |
| ENSG00000262202.3 |
Axitinib |
Brain lower grade glioma |
0.003449413 |
Resistant |
| ENSG00000263176.1 |
Axitinib |
Brain lower grade glioma |
0.026099275 |
Resistant |
| ENSG00000264125.1 |
Axitinib |
Brain lower grade glioma |
0.010816414 |
Resistant |
| ENSG00000266677.1 |
Axitinib |
Brain lower grade glioma |
0.030677481 |
Resistant |
| ENSG00000266801.1 |
Axitinib |
Brain lower grade glioma |
0.013030537 |
Resistant |
| ENSG00000266957.1 |
Axitinib |
Brain lower grade glioma |
0.048999702 |
Resistant |
| ENSG00000266968.1 |
Axitinib |
Brain lower grade glioma |
0.0485426 |
Resistant |
| ENSG00000267010.1 |
Axitinib |
Brain lower grade glioma |
0.03066506 |
Resistant |
| ENSG00000267118.1 |
Axitinib |
Brain lower grade glioma |
0.016897155 |
Resistant |
| ENSG00000267272.1 |
Axitinib |
Brain lower grade glioma |
0.041206554 |
Resistant |
| ENSG00000267390.1 |
Axitinib |
Brain lower grade glioma |
0.047834851 |
Resistant |
| ENSG00000267476.1 |
Axitinib |
Brain lower grade glioma |
0.041962593 |
Resistant |
| ENSG00000267567.1 |
Axitinib |
Brain lower grade glioma |
0.009901446 |
Resistant |
| ENSG00000267705.1 |
Axitinib |
Brain lower grade glioma |
0.036694133 |
Resistant |
| ENSG00000267798.1 |
Axitinib |
Brain lower grade glioma |
0.001370394 |
Resistant |
| ENSG00000268458.1 |
Axitinib |
Brain lower grade glioma |
0.044449156 |
Resistant |
| ENSG00000269966.1 |
Axitinib |
Brain lower grade glioma |
0.048371844 |
Resistant |
| ENSG00000270031.1 |
Axitinib |
Brain lower grade glioma |
0.0264752 |
Resistant |
| ENSG00000270067.1 |
Axitinib |
Brain lower grade glioma |
0.001877705 |
Resistant |
| ENSG00000270124.1 |
Axitinib |
Brain lower grade glioma |
0.030130479 |
Resistant |
| ENSG00000270640.1 |
Axitinib |
Brain lower grade glioma |
0.000816218 |
Resistant |
| ENSG00000271367.1 |
Axitinib |
Brain lower grade glioma |
0.015668063 |
Resistant |
| ENSG00000271743.1 |
Axitinib |
Brain lower grade glioma |
0.018590396 |
Resistant |
| ENSG00000271843.1 |
Axitinib |
Brain lower grade glioma |
0.009192966 |
Resistant |
| ENSG00000271914.1 |
Axitinib |
Brain lower grade glioma |
0.022037007 |
Resistant |
| ENSG00000271927.1 |
Axitinib |
Brain lower grade glioma |
0.022089891 |
Resistant |
| ENSG00000272003.1 |
Axitinib |
Brain lower grade glioma |
0.012877794 |
Resistant |
| ENSG00000272029.1 |
Axitinib |
Brain lower grade glioma |
0.001382308 |
Resistant |
| ENSG00000272081.1 |
Axitinib |
Brain lower grade glioma |
0.041294815 |
Resistant |
| ENSG00000272103.1 |
Axitinib |
Brain lower grade glioma |
0.044718256 |
Resistant |
| ENSG00000272361.1 |
Axitinib |
Brain lower grade glioma |
0.014841562 |
Resistant |
| ENSG00000272368.1 |
Axitinib |
Brain lower grade glioma |
0.0014992 |
Resistant |
| ENSG00000272370.1 |
Axitinib |
Brain lower grade glioma |
0.038506822 |
Resistant |
| ENSG00000272389.1 |
Axitinib |
Brain lower grade glioma |
0.033623169 |
Resistant |
| ENSG00000272411.1 |
Axitinib |
Brain lower grade glioma |
0.024035472 |
Resistant |
| ENSG00000272650.1 |
Axitinib |
Brain lower grade glioma |
0.034358246 |
Resistant |
| ENSG00000272657.1 |
Axitinib |
Brain lower grade glioma |
0.009103962 |
Resistant |
| ENSG00000272689.1 |
Axitinib |
Brain lower grade glioma |
0.031435178 |
Resistant |
| ENSG00000272690.1 |
Axitinib |
Brain lower grade glioma |
0.042849623 |
Resistant |
| ENSG00000272719.1 |
Axitinib |
Brain lower grade glioma |
0.031873379 |
Resistant |
| ENSG00000272905.1 |
Axitinib |
Brain lower grade glioma |
0.016731245 |
Resistant |
| ENSG00000273125.1 |
Axitinib |
Brain lower grade glioma |
0.035664723 |
Resistant |
| ENSG00000273131.1 |
Axitinib |
Brain lower grade glioma |
0.034405504 |
Resistant |
| ENSG00000273233.1 |
Axitinib |
Brain lower grade glioma |
0.01857873 |
Resistant |
| ENSG00000273307.1 |
Axitinib |
Brain lower grade glioma |
0.001824994 |
Resistant |
| ENSG00000273319.1 |
Axitinib |
Brain lower grade glioma |
0.042070805 |
Resistant |
| ENSG00000273428.1 |
Axitinib |
Brain lower grade glioma |
0.03015566 |
Resistant |
| ENSG00000273464.1 |
Axitinib |
Brain lower grade glioma |
0.016181361 |
Resistant |
| ENSG00000175773.8 |
Axitinib |
Lung squamous cell carcinoma |
0.008930132 |
Resistant |
| ENSG00000177337.3 |
Axitinib |
Lung squamous cell carcinoma |
0.030994901 |
Resistant |
| ENSG00000177406.4 |
Axitinib |
Lung squamous cell carcinoma |
0.033379198 |
Resistant |
| ENSG00000182057.4 |
Axitinib |
Lung squamous cell carcinoma |
0.025849168 |
Resistant |
| ENSG00000182648.7 |
Axitinib |
Lung squamous cell carcinoma |
0.004192363 |
Resistant |
| ENSG00000185168.5 |
Axitinib |
Lung squamous cell carcinoma |
0.036679342 |
Resistant |
| ENSG00000189238.4 |
Axitinib |
Lung squamous cell carcinoma |
0.017857659 |
Resistant |
| ENSG00000197099.4 |
Axitinib |
Lung squamous cell carcinoma |
0.042983011 |
Resistant |
| ENSG00000198106.7 |
Axitinib |
Lung squamous cell carcinoma |
0.035173466 |
Resistant |
| ENSG00000203999.4 |
Axitinib |
Lung squamous cell carcinoma |
0.029794128 |
Resistant |
| ENSG00000206113.3 |
Axitinib |
Lung squamous cell carcinoma |
0.039651736 |
Resistant |
| ENSG00000213963.2 |
Axitinib |
Lung squamous cell carcinoma |
0.023054128 |
Resistant |
| ENSG00000214146.2 |
Axitinib |
Lung squamous cell carcinoma |
0.009665197 |
Resistant |
| ENSG00000215068.3 |
Axitinib |
Lung squamous cell carcinoma |
0.044324753 |
Resistant |
| ENSG00000215841.3 |
Axitinib |
Lung squamous cell carcinoma |
0.011992411 |
Resistant |
| ENSG00000222043.2 |
Axitinib |
Lung squamous cell carcinoma |
0.015422695 |
Resistant |
| ENSG00000223653.1 |
Axitinib |
Lung squamous cell carcinoma |
0.030833089 |
Resistant |
| ENSG00000223759.2 |
Axitinib |
Lung squamous cell carcinoma |
0.035617523 |
Resistant |
| ENSG00000224621.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002950982 |
Resistant |
| ENSG00000224764.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047950848 |
Resistant |
| ENSG00000224799.1 |
Axitinib |
Lung squamous cell carcinoma |
0.048184103 |
Resistant |
| ENSG00000224848.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021391148 |
Resistant |
| ENSG00000224897.2 |
Axitinib |
Lung squamous cell carcinoma |
0.033442136 |
Resistant |
| ENSG00000224945.1 |
Axitinib |
Lung squamous cell carcinoma |
0.016851306 |
Resistant |
| ENSG00000225077.2 |
Axitinib |
Lung squamous cell carcinoma |
0.021743174 |
Resistant |
| ENSG00000225335.2 |
Axitinib |
Lung squamous cell carcinoma |
0.001143905 |
Resistant |
| ENSG00000225521.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047128785 |
Resistant |
| ENSG00000225535.2 |
Axitinib |
Lung squamous cell carcinoma |
0.012661157 |
Resistant |
| ENSG00000225836.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040992935 |
Resistant |
| ENSG00000225969.1 |
Axitinib |
Lung squamous cell carcinoma |
0.043697598 |
Resistant |
| ENSG00000226067.2 |
Axitinib |
Lung squamous cell carcinoma |
0.047701004 |
Resistant |
| ENSG00000226263.1 |
Axitinib |
Lung squamous cell carcinoma |
0.028243092 |
Resistant |
| ENSG00000226310.1 |
Axitinib |
Lung squamous cell carcinoma |
0.004209844 |
Resistant |
| ENSG00000226465.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046235056 |
Resistant |
| ENSG00000226690.2 |
Axitinib |
Lung squamous cell carcinoma |
0.034998162 |
Resistant |
| ENSG00000226756.1 |
Axitinib |
Lung squamous cell carcinoma |
0.001177433 |
Resistant |
| ENSG00000227036.2 |
Axitinib |
Lung squamous cell carcinoma |
0.031428602 |
Resistant |
| ENSG00000227053.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021517258 |
Resistant |
| ENSG00000227070.1 |
Axitinib |
Lung squamous cell carcinoma |
0.006030772 |
Resistant |
| ENSG00000227117.2 |
Axitinib |
Lung squamous cell carcinoma |
0.033950048 |
Resistant |
| ENSG00000227214.2 |
Axitinib |
Lung squamous cell carcinoma |
0.043982884 |
Resistant |
| ENSG00000227403.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0000697 |
Resistant |
| ENSG00000227959.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002122015 |
Resistant |
| ENSG00000228013.1 |
Axitinib |
Lung squamous cell carcinoma |
0.039724107 |
Resistant |
| ENSG00000228084.1 |
Axitinib |
Lung squamous cell carcinoma |
0.00437462 |
Resistant |
| ENSG00000228113.3 |
Axitinib |
Lung squamous cell carcinoma |
0.013708187 |
Resistant |
| ENSG00000228150.1 |
Axitinib |
Lung squamous cell carcinoma |
0.013648286 |
Resistant |
| ENSG00000228397.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04395539 |
Resistant |
| ENSG00000228598.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010310629 |
Resistant |
| ENSG00000228624.3 |
Axitinib |
Lung squamous cell carcinoma |
0.00531567 |
Resistant |
| ENSG00000228701.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046553268 |
Resistant |
| ENSG00000229291.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032488134 |
Resistant |
| ENSG00000229628.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040078253 |
Resistant |
| ENSG00000229666.1 |
Axitinib |
Lung squamous cell carcinoma |
0.006329798 |
Resistant |
| ENSG00000229893.1 |
Axitinib |
Lung squamous cell carcinoma |
0.009578621 |
Resistant |
| ENSG00000229970.3 |
Axitinib |
Lung squamous cell carcinoma |
0.020770148 |
Resistant |
| ENSG00000229996.1 |
Axitinib |
Lung squamous cell carcinoma |
0.041088351 |
Resistant |
| ENSG00000230102.3 |
Axitinib |
Lung squamous cell carcinoma |
0.008989232 |
Resistant |
| ENSG00000230479.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027526853 |
Resistant |
| ENSG00000230513.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047392147 |
Resistant |
| ENSG00000230534.2 |
Axitinib |
Lung squamous cell carcinoma |
0.027041739 |
Resistant |
| ENSG00000230943.1 |
Axitinib |
Lung squamous cell carcinoma |
0.035896334 |
Resistant |
| ENSG00000231170.1 |
Axitinib |
Lung squamous cell carcinoma |
0.043011791 |
Resistant |
| ENSG00000231226.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021095819 |
Resistant |
| ENSG00000231298.2 |
Axitinib |
Lung squamous cell carcinoma |
0.046096774 |
Resistant |
| ENSG00000231312.2 |
Axitinib |
Lung squamous cell carcinoma |
0.02471118 |
Resistant |
| ENSG00000231335.1 |
Axitinib |
Lung squamous cell carcinoma |
0.011890547 |
Resistant |
| ENSG00000231486.3 |
Axitinib |
Lung squamous cell carcinoma |
0.047228082 |
Resistant |
| ENSG00000231721.2 |
Axitinib |
Lung squamous cell carcinoma |
0.039053466 |
Resistant |
| ENSG00000231903.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017630347 |
Resistant |
| ENSG00000231920.1 |
Axitinib |
Lung squamous cell carcinoma |
0.038668773 |
Resistant |
| ENSG00000232298.2 |
Axitinib |
Lung squamous cell carcinoma |
0.011345792 |
Resistant |
| ENSG00000232386.5 |
Axitinib |
Lung squamous cell carcinoma |
0.015962345 |
Resistant |
| ENSG00000232453.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03179016 |
Resistant |
| ENSG00000232504.4 |
Axitinib |
Lung squamous cell carcinoma |
0.043157854 |
Resistant |
| ENSG00000232533.1 |
Axitinib |
Lung squamous cell carcinoma |
0.030298988 |
Resistant |
| ENSG00000232693.2 |
Axitinib |
Lung squamous cell carcinoma |
0.027856448 |
Resistant |
| ENSG00000232759.1 |
Axitinib |
Lung squamous cell carcinoma |
0.041707526 |
Resistant |
| ENSG00000232896.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04004858 |
Resistant |
| ENSG00000232936.1 |
Axitinib |
Lung squamous cell carcinoma |
0.013703315 |
Resistant |
| ENSG00000232949.1 |
Axitinib |
Lung squamous cell carcinoma |
0.019845001 |
Resistant |
| ENSG00000233077.1 |
Axitinib |
Lung squamous cell carcinoma |
0.030158851 |
Resistant |
| ENSG00000233351.1 |
Axitinib |
Lung squamous cell carcinoma |
0.024724555 |
Resistant |
| ENSG00000233358.2 |
Axitinib |
Lung squamous cell carcinoma |
0.045475064 |
Resistant |
| ENSG00000233421.3 |
Axitinib |
Lung squamous cell carcinoma |
0.027717644 |
Resistant |
| ENSG00000233818.1 |
Axitinib |
Lung squamous cell carcinoma |
0.042567322 |
Resistant |
| ENSG00000233845.1 |
Axitinib |
Lung squamous cell carcinoma |
0.003598837 |
Resistant |
| ENSG00000233860.1 |
Axitinib |
Lung squamous cell carcinoma |
0.008697226 |
Resistant |
| ENSG00000233912.1 |
Axitinib |
Lung squamous cell carcinoma |
0.00316813 |
Resistant |
| ENSG00000234070.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027552656 |
Resistant |
| ENSG00000234076.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002275669 |
Resistant |
| ENSG00000234141.1 |
Axitinib |
Lung squamous cell carcinoma |
0.041981956 |
Resistant |
| ENSG00000234147.1 |
Axitinib |
Lung squamous cell carcinoma |
0.039284185 |
Resistant |
| ENSG00000234197.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0000654 |
Resistant |
| ENSG00000234255.4 |
Axitinib |
Lung squamous cell carcinoma |
0.03009424 |
Resistant |
| ENSG00000234396.3 |
Axitinib |
Lung squamous cell carcinoma |
0.010433092 |
Resistant |
| ENSG00000234572.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010003112 |
Resistant |
| ENSG00000234584.1 |
Axitinib |
Lung squamous cell carcinoma |
0.039570696 |
Resistant |
| ENSG00000234614.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032650328 |
Resistant |
| ENSG00000234663.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03406335 |
Resistant |
| ENSG00000234690.2 |
Axitinib |
Lung squamous cell carcinoma |
0.004153325 |
Resistant |
| ENSG00000234807.4 |
Axitinib |
Lung squamous cell carcinoma |
0.019181691 |
Resistant |
| ENSG00000235042.1 |
Axitinib |
Lung squamous cell carcinoma |
0.026582917 |
Resistant |
| ENSG00000235214.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04032674 |
Resistant |
| ENSG00000235419.1 |
Axitinib |
Lung squamous cell carcinoma |
0.025708129 |
Resistant |
| ENSG00000235501.1 |
Axitinib |
Lung squamous cell carcinoma |
0.012014242 |
Resistant |
| ENSG00000235663.1 |
Axitinib |
Lung squamous cell carcinoma |
0.003649995 |
Resistant |
| ENSG00000235724.4 |
Axitinib |
Lung squamous cell carcinoma |
0.0000856 |
Resistant |
| ENSG00000235725.1 |
Axitinib |
Lung squamous cell carcinoma |
0.036350711 |
Resistant |
| ENSG00000235781.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010625799 |
Resistant |
| ENSG00000235848.2 |
Axitinib |
Lung squamous cell carcinoma |
0.037060185 |
Resistant |
| ENSG00000235999.1 |
Axitinib |
Lung squamous cell carcinoma |
0.036106704 |
Resistant |
| ENSG00000236153.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010616932 |
Resistant |
| ENSG00000236204.1 |
Axitinib |
Lung squamous cell carcinoma |
0.004354456 |
Resistant |
| ENSG00000236212.1 |
Axitinib |
Lung squamous cell carcinoma |
0.02528544 |
Resistant |
| ENSG00000236305.1 |
Axitinib |
Lung squamous cell carcinoma |
0.038020269 |
Resistant |
| ENSG00000236345.1 |
Axitinib |
Lung squamous cell carcinoma |
0.012637952 |
Resistant |
| ENSG00000236528.1 |
Axitinib |
Lung squamous cell carcinoma |
0.003667941 |
Resistant |
| ENSG00000236671.3 |
Axitinib |
Lung squamous cell carcinoma |
0.034973783 |
Resistant |
| ENSG00000236753.1 |
Axitinib |
Lung squamous cell carcinoma |
0.003061708 |
Resistant |
| ENSG00000236846.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04876781 |
Resistant |
| ENSG00000236914.3 |
Axitinib |
Lung squamous cell carcinoma |
0.011643715 |
Resistant |
| ENSG00000236936.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047578406 |
Resistant |
| ENSG00000237301.1 |
Axitinib |
Lung squamous cell carcinoma |
0.013089057 |
Resistant |
| ENSG00000237453.1 |
Axitinib |
Lung squamous cell carcinoma |
0.037478542 |
Resistant |
| ENSG00000237476.1 |
Axitinib |
Lung squamous cell carcinoma |
0.024479372 |
Resistant |
| ENSG00000237505.2 |
Axitinib |
Lung squamous cell carcinoma |
0.02726701 |
Resistant |
| ENSG00000237525.2 |
Axitinib |
Lung squamous cell carcinoma |
0.037283717 |
Resistant |
| ENSG00000237697.2 |
Axitinib |
Lung squamous cell carcinoma |
0.037679258 |
Resistant |
| ENSG00000237764.2 |
Axitinib |
Lung squamous cell carcinoma |
0.038006483 |
Resistant |
| ENSG00000237877.2 |
Axitinib |
Lung squamous cell carcinoma |
0.019727502 |
Resistant |
| ENSG00000237978.1 |
Axitinib |
Lung squamous cell carcinoma |
0.042374681 |
Resistant |
| ENSG00000238273.3 |
Axitinib |
Lung squamous cell carcinoma |
0.049366448 |
Resistant |
| ENSG00000238280.1 |
Axitinib |
Lung squamous cell carcinoma |
0.039433024 |
Resistant |
| ENSG00000239593.1 |
Axitinib |
Lung squamous cell carcinoma |
0.045836033 |
Resistant |
| ENSG00000239920.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032162802 |
Resistant |
| ENSG00000240005.1 |
Axitinib |
Lung squamous cell carcinoma |
0.014989357 |
Resistant |
| ENSG00000240875.1 |
Axitinib |
Lung squamous cell carcinoma |
0.00706083 |
Resistant |
| ENSG00000241155.1 |
Axitinib |
Lung squamous cell carcinoma |
0.009733477 |
Resistant |
| ENSG00000241525.3 |
Axitinib |
Lung squamous cell carcinoma |
0.03518236 |
Resistant |
| ENSG00000242349.1 |
Axitinib |
Lung squamous cell carcinoma |
0.012458433 |
Resistant |
| ENSG00000242753.1 |
Axitinib |
Lung squamous cell carcinoma |
0.038029853 |
Resistant |
| ENSG00000243069.3 |
Axitinib |
Lung squamous cell carcinoma |
0.042864546 |
Resistant |
| ENSG00000243176.1 |
Axitinib |
Lung squamous cell carcinoma |
0.018775147 |
Resistant |
| ENSG00000244198.1 |
Axitinib |
Lung squamous cell carcinoma |
0.016519034 |
Resistant |
| ENSG00000244459.2 |
Axitinib |
Lung squamous cell carcinoma |
0.022233187 |
Resistant |
| ENSG00000244791.2 |
Axitinib |
Lung squamous cell carcinoma |
0.035849167 |
Resistant |
| ENSG00000244968.2 |
Axitinib |
Lung squamous cell carcinoma |
0.038202892 |
Resistant |
| ENSG00000245059.2 |
Axitinib |
Lung squamous cell carcinoma |
0.009097764 |
Resistant |
| ENSG00000245281.2 |
Axitinib |
Lung squamous cell carcinoma |
0.022624703 |
Resistant |
| ENSG00000246523.3 |
Axitinib |
Lung squamous cell carcinoma |
0.008074812 |
Resistant |
| ENSG00000246526.2 |
Axitinib |
Lung squamous cell carcinoma |
0.029538134 |
Resistant |
| ENSG00000246548.3 |
Axitinib |
Lung squamous cell carcinoma |
0.027442254 |
Resistant |
| ENSG00000247774.2 |
Axitinib |
Lung squamous cell carcinoma |
0.049048425 |
Resistant |
| ENSG00000247809.3 |
Axitinib |
Lung squamous cell carcinoma |
0.012352526 |
Resistant |
| ENSG00000248161.1 |
Axitinib |
Lung squamous cell carcinoma |
0.007494764 |
Resistant |
| ENSG00000248243.1 |
Axitinib |
Lung squamous cell carcinoma |
0.035273872 |
Resistant |
| ENSG00000248515.1 |
Axitinib |
Lung squamous cell carcinoma |
0.020428889 |
Resistant |
| ENSG00000248973.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040807635 |
Resistant |
| ENSG00000249574.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027823493 |
Resistant |
| ENSG00000249631.1 |
Axitinib |
Lung squamous cell carcinoma |
0.029381922 |
Resistant |
| ENSG00000249685.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040072716 |
Resistant |
| ENSG00000249942.1 |
Axitinib |
Lung squamous cell carcinoma |
0.026008812 |
Resistant |
| ENSG00000250073.2 |
Axitinib |
Lung squamous cell carcinoma |
0.019511966 |
Resistant |
| ENSG00000250220.1 |
Axitinib |
Lung squamous cell carcinoma |
0.01009328 |
Resistant |
| ENSG00000250508.1 |
Axitinib |
Lung squamous cell carcinoma |
0.023018513 |
Resistant |
| ENSG00000250590.1 |
Axitinib |
Lung squamous cell carcinoma |
0.036431753 |
Resistant |
| ENSG00000250596.1 |
Axitinib |
Lung squamous cell carcinoma |
0.005952539 |
Resistant |
| ENSG00000250874.1 |
Axitinib |
Lung squamous cell carcinoma |
0.035819434 |
Resistant |
| ENSG00000251026.1 |
Axitinib |
Lung squamous cell carcinoma |
0.043919171 |
Resistant |
| ENSG00000251169.2 |
Axitinib |
Lung squamous cell carcinoma |
0.013706129 |
Resistant |
| ENSG00000253111.1 |
Axitinib |
Lung squamous cell carcinoma |
0.035510066 |
Resistant |
| ENSG00000253133.1 |
Axitinib |
Lung squamous cell carcinoma |
0.020133889 |
Resistant |
| ENSG00000253197.1 |
Axitinib |
Lung squamous cell carcinoma |
0.036584043 |
Resistant |
| ENSG00000253266.1 |
Axitinib |
Lung squamous cell carcinoma |
0.008354709 |
Resistant |
| ENSG00000253335.1 |
Axitinib |
Lung squamous cell carcinoma |
0.037447769 |
Resistant |
| ENSG00000253395.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017972724 |
Resistant |
| ENSG00000253532.1 |
Axitinib |
Lung squamous cell carcinoma |
0.005451509 |
Resistant |
| ENSG00000253616.1 |
Axitinib |
Lung squamous cell carcinoma |
0.031828769 |
Resistant |
| ENSG00000253671.1 |
Axitinib |
Lung squamous cell carcinoma |
0.019485191 |
Resistant |
| ENSG00000254044.1 |
Axitinib |
Lung squamous cell carcinoma |
0.029588872 |
Resistant |
| ENSG00000254081.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021894935 |
Resistant |
| ENSG00000254154.4 |
Axitinib |
Lung squamous cell carcinoma |
0.027621898 |
Resistant |
| ENSG00000254286.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032257075 |
Resistant |
| ENSG00000254431.1 |
Axitinib |
Lung squamous cell carcinoma |
0.014927988 |
Resistant |
| ENSG00000254458.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049851098 |
Resistant |
| ENSG00000254574.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027636334 |
Resistant |
| ENSG00000254731.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017550111 |
Resistant |
| ENSG00000254837.1 |
Axitinib |
Lung squamous cell carcinoma |
0.005961684 |
Resistant |
| ENSG00000254855.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03936682 |
Resistant |
| ENSG00000254985.1 |
Axitinib |
Lung squamous cell carcinoma |
0.043017006 |
Resistant |
| ENSG00000255320.1 |
Axitinib |
Lung squamous cell carcinoma |
0.005495664 |
Resistant |
| ENSG00000255435.2 |
Axitinib |
Lung squamous cell carcinoma |
0.002234063 |
Resistant |
| ENSG00000255507.1 |
Axitinib |
Lung squamous cell carcinoma |
0.033504195 |
Resistant |
| ENSG00000255539.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047800006 |
Resistant |
| ENSG00000255650.1 |
Axitinib |
Lung squamous cell carcinoma |
0.048423067 |
Resistant |
| ENSG00000255723.1 |
Axitinib |
Lung squamous cell carcinoma |
0.02312603 |
Resistant |
| ENSG00000256001.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03656941 |
Resistant |
| ENSG00000256128.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049616889 |
Resistant |
| ENSG00000256151.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021619638 |
Resistant |
| ENSG00000256312.1 |
Axitinib |
Lung squamous cell carcinoma |
0.014653205 |
Resistant |
| ENSG00000257156.1 |
Axitinib |
Lung squamous cell carcinoma |
0.020384968 |
Resistant |
| ENSG00000257261.1 |
Axitinib |
Lung squamous cell carcinoma |
0.000271233 |
Resistant |
| ENSG00000257449.1 |
Axitinib |
Lung squamous cell carcinoma |
0.031396041 |
Resistant |
| ENSG00000257526.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017224937 |
Resistant |
| ENSG00000257557.1 |
Axitinib |
Lung squamous cell carcinoma |
0.005420134 |
Resistant |
| ENSG00000257831.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04298212 |
Resistant |
| ENSG00000258451.1 |
Axitinib |
Lung squamous cell carcinoma |
0.02166208 |
Resistant |
| ENSG00000258534.1 |
Axitinib |
Lung squamous cell carcinoma |
0.008955919 |
Resistant |
| ENSG00000258561.1 |
Axitinib |
Lung squamous cell carcinoma |
0.008279702 |
Resistant |
| ENSG00000258735.1 |
Axitinib |
Lung squamous cell carcinoma |
0.005454053 |
Resistant |
| ENSG00000258914.1 |
Axitinib |
Lung squamous cell carcinoma |
0.012078288 |
Resistant |
| ENSG00000259006.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032921117 |
Resistant |
| ENSG00000259065.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046778259 |
Resistant |
| ENSG00000259275.1 |
Axitinib |
Lung squamous cell carcinoma |
0.044978178 |
Resistant |
| ENSG00000259438.1 |
Axitinib |
Lung squamous cell carcinoma |
0.006154243 |
Resistant |
| ENSG00000259542.1 |
Axitinib |
Lung squamous cell carcinoma |
0.028565397 |
Resistant |
| ENSG00000259584.1 |
Axitinib |
Lung squamous cell carcinoma |
0.045128447 |
Resistant |
| ENSG00000259654.1 |
Axitinib |
Lung squamous cell carcinoma |
0.00778468 |
Resistant |
| ENSG00000259687.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049206303 |
Resistant |
| ENSG00000259915.1 |
Axitinib |
Lung squamous cell carcinoma |
0.042777786 |
Resistant |
| ENSG00000260008.1 |
Axitinib |
Lung squamous cell carcinoma |
0.036879924 |
Resistant |
| ENSG00000260018.1 |
Axitinib |
Lung squamous cell carcinoma |
0.019647385 |
Resistant |
| ENSG00000260021.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04692241 |
Resistant |
| ENSG00000260052.1 |
Axitinib |
Lung squamous cell carcinoma |
0.023728418 |
Resistant |
| ENSG00000260059.1 |
Axitinib |
Lung squamous cell carcinoma |
0.019323409 |
Resistant |
| ENSG00000260156.1 |
Axitinib |
Lung squamous cell carcinoma |
0.024297348 |
Resistant |
| ENSG00000260239.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049867895 |
Resistant |
| ENSG00000260430.1 |
Axitinib |
Lung squamous cell carcinoma |
0.02771987 |
Resistant |
| ENSG00000260550.2 |
Axitinib |
Lung squamous cell carcinoma |
0.011065387 |
Resistant |
| ENSG00000260577.1 |
Axitinib |
Lung squamous cell carcinoma |
0.034489471 |
Resistant |
| ENSG00000260744.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046787392 |
Resistant |
| ENSG00000260757.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03208304 |
Resistant |
| ENSG00000260792.1 |
Axitinib |
Lung squamous cell carcinoma |
0.044693261 |
Resistant |
| ENSG00000260805.1 |
Axitinib |
Lung squamous cell carcinoma |
0.037537896 |
Resistant |
| ENSG00000260971.3 |
Axitinib |
Lung squamous cell carcinoma |
0.030286918 |
Resistant |
| ENSG00000261141.1 |
Axitinib |
Lung squamous cell carcinoma |
0.028290422 |
Resistant |
| ENSG00000261373.1 |
Axitinib |
Lung squamous cell carcinoma |
0.004888776 |
Resistant |
| ENSG00000261379.1 |
Axitinib |
Lung squamous cell carcinoma |
0.034313788 |
Resistant |
| ENSG00000261407.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032832761 |
Resistant |
| ENSG00000261431.1 |
Axitinib |
Lung squamous cell carcinoma |
0.045338806 |
Resistant |
| ENSG00000261523.1 |
Axitinib |
Lung squamous cell carcinoma |
0.009796327 |
Resistant |
| ENSG00000261737.1 |
Axitinib |
Lung squamous cell carcinoma |
0.022265039 |
Resistant |
| ENSG00000261760.2 |
Axitinib |
Lung squamous cell carcinoma |
0.021406279 |
Resistant |
| ENSG00000261864.1 |
Axitinib |
Lung squamous cell carcinoma |
0.01376263 |
Resistant |
| ENSG00000262136.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002937737 |
Resistant |
| ENSG00000263325.1 |
Axitinib |
Lung squamous cell carcinoma |
0.036493668 |
Resistant |
| ENSG00000263327.2 |
Axitinib |
Lung squamous cell carcinoma |
0.002156286 |
Resistant |
| ENSG00000263338.1 |
Axitinib |
Lung squamous cell carcinoma |
0.016527393 |
Resistant |
| ENSG00000263680.2 |
Axitinib |
Lung squamous cell carcinoma |
0.026088779 |
Resistant |
| ENSG00000264859.1 |
Axitinib |
Lung squamous cell carcinoma |
0.018310034 |
Resistant |
| ENSG00000265246.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027843374 |
Resistant |
| ENSG00000265702.1 |
Axitinib |
Lung squamous cell carcinoma |
0.041466979 |
Resistant |
| ENSG00000265888.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03069374 |
Resistant |
| ENSG00000266401.1 |
Axitinib |
Lung squamous cell carcinoma |
0.041787628 |
Resistant |
| ENSG00000266521.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040253942 |
Resistant |
| ENSG00000267082.1 |
Axitinib |
Lung squamous cell carcinoma |
0.015954733 |
Resistant |
| ENSG00000267737.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0202433 |
Resistant |
| ENSG00000267751.1 |
Axitinib |
Lung squamous cell carcinoma |
0.004660953 |
Resistant |
| ENSG00000268061.1 |
Axitinib |
Lung squamous cell carcinoma |
0.015972943 |
Resistant |
| ENSG00000268186.1 |
Axitinib |
Lung squamous cell carcinoma |
0.030114269 |
Resistant |
| ENSG00000268686.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046590865 |
Resistant |
| ENSG00000269082.1 |
Axitinib |
Lung squamous cell carcinoma |
0.025063558 |
Resistant |
| ENSG00000269481.1 |
Axitinib |
Lung squamous cell carcinoma |
0.014800639 |
Resistant |
| ENSG00000269640.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017986348 |
Resistant |
| ENSG00000269720.1 |
Axitinib |
Lung squamous cell carcinoma |
0.038935923 |
Resistant |
| ENSG00000269895.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03495603 |
Resistant |
| ENSG00000269901.1 |
Axitinib |
Lung squamous cell carcinoma |
0.011536291 |
Resistant |
| ENSG00000270659.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002275376 |
Resistant |
| ENSG00000271133.1 |
Axitinib |
Lung squamous cell carcinoma |
0.02148678 |
Resistant |
| ENSG00000271780.1 |
Axitinib |
Lung squamous cell carcinoma |
0.003062174 |
Resistant |
| ENSG00000271874.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046393858 |
Resistant |
| ENSG00000271983.1 |
Axitinib |
Lung squamous cell carcinoma |
0.01373122 |
Resistant |
| ENSG00000272328.1 |
Axitinib |
Lung squamous cell carcinoma |
0.020995464 |
Resistant |
| ENSG00000272369.1 |
Axitinib |
Lung squamous cell carcinoma |
0.015846705 |
Resistant |
| ENSG00000272444.1 |
Axitinib |
Lung squamous cell carcinoma |
0.007239799 |
Resistant |
| ENSG00000272583.1 |
Axitinib |
Lung squamous cell carcinoma |
0.044431046 |
Resistant |
| ENSG00000272682.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0149658 |
Resistant |
| ENSG00000272735.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017450092 |
Resistant |
| ENSG00000272769.1 |
Axitinib |
Lung squamous cell carcinoma |
0.045692878 |
Resistant |
| ENSG00000272829.1 |
Axitinib |
Lung squamous cell carcinoma |
0.042603118 |
Resistant |
| ENSG00000272894.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047098425 |
Resistant |
| ENSG00000272913.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027361227 |
Resistant |
| ENSG00000272917.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017709419 |
Resistant |
| ENSG00000273125.1 |
Axitinib |
Lung squamous cell carcinoma |
0.008240971 |
Resistant |
| ENSG00000273132.1 |
Axitinib |
Lung squamous cell carcinoma |
0.01849059 |
Resistant |
| ENSG00000273186.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010028894 |
Resistant |
| ENSG00000273272.1 |
Axitinib |
Lung squamous cell carcinoma |
0.030934359 |
Resistant |
| ENSG00000273305.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0394619 |
Resistant |
| ENSG00000273355.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017340374 |
Resistant |
| ENSG00000146666.4 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02081519 |
Resistant |
| ENSG00000203999.4 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007618125 |
Resistant |
| ENSG00000204860.4 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043552242 |
Resistant |
| ENSG00000204949.4 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044554087 |
Resistant |
| ENSG00000224468.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024741805 |
Resistant |
| ENSG00000225791.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046962406 |
Resistant |
| ENSG00000225973.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041633181 |
Resistant |
| ENSG00000229556.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03282753 |
Resistant |
| ENSG00000231728.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048555542 |
Resistant |
| ENSG00000231794.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046728002 |
Resistant |
| ENSG00000233144.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034561066 |
Resistant |
| ENSG00000233817.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037526824 |
Resistant |
| ENSG00000233848.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035307766 |
Resistant |
| ENSG00000234206.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019366413 |
Resistant |
| ENSG00000235726.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013584515 |
Resistant |
| ENSG00000235884.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016274258 |
Resistant |
| ENSG00000237813.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030213927 |
Resistant |
| ENSG00000245275.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048551606 |
Resistant |
| ENSG00000249001.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020753293 |
Resistant |
| ENSG00000250548.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047574037 |
Resistant |
| ENSG00000251131.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019421347 |
Resistant |
| ENSG00000253730.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034936171 |
Resistant |
| ENSG00000254027.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043176193 |
Resistant |
| ENSG00000257381.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040695268 |
Resistant |
| ENSG00000257698.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006910424 |
Resistant |
| ENSG00000257718.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016156006 |
Resistant |
| ENSG00000257735.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000430885 |
Resistant |
| ENSG00000257999.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006782076 |
Resistant |
| ENSG00000258983.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028901707 |
Resistant |
| ENSG00000259250.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047793023 |
Resistant |
| ENSG00000259589.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006329918 |
Resistant |
| ENSG00000260349.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030209033 |
Resistant |
| ENSG00000262001.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006119602 |
Resistant |
| ENSG00000263924.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016219733 |
Resistant |
| ENSG00000266896.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047566853 |
Resistant |
| ENSG00000270104.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016421947 |
Resistant |
| ENSG00000271359.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042872843 |
Resistant |
| ENSG00000271978.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005301955 |
Resistant |
| ENSG00000272029.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029092494 |
Resistant |
| ENSG00000205885.3 |
Axitinib |
Pancreatic adenocarcinoma |
0.038478406 |
Resistant |
| ENSG00000223546.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.019894478 |
Resistant |
| ENSG00000226876.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.026628521 |
Resistant |
| ENSG00000227214.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.030560185 |
Resistant |
| ENSG00000228251.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.00248104 |
Resistant |
| ENSG00000228677.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.049913878 |
Resistant |
| ENSG00000229656.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.032126174 |
Resistant |
| ENSG00000229874.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.007554736 |
Resistant |
| ENSG00000236581.4 |
Axitinib |
Pancreatic adenocarcinoma |
0.037276461 |
Resistant |
| ENSG00000249279.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.021587333 |
Resistant |
| ENSG00000253372.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.036721914 |
Resistant |
| ENSG00000261200.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.019352689 |
Resistant |
| ENSG00000261505.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.034027216 |
Resistant |
| ENSG00000269825.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.012623088 |
Resistant |
| ENSG00000269923.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.037961843 |
Resistant |
| ENSG00000270009.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.027124765 |
Resistant |
| ENSG00000272341.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.02433956 |
Resistant |
| ENSG00000273002.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.029718588 |
Resistant |
| ENSG00000163364.5 |
Axitinib |
Sarcoma |
0.042019335 |
Resistant |
| ENSG00000184274.3 |
Axitinib |
Sarcoma |
0.004862388 |
Resistant |
| ENSG00000224209.2 |
Axitinib |
Sarcoma |
0.035519443 |
Resistant |
| ENSG00000225030.1 |
Axitinib |
Sarcoma |
0.038639409 |
Resistant |
| ENSG00000225205.1 |
Axitinib |
Sarcoma |
0.049500879 |
Resistant |
| ENSG00000225206.4 |
Axitinib |
Sarcoma |
0.017213103 |
Resistant |
| ENSG00000225953.2 |
Axitinib |
Sarcoma |
0.035645622 |
Resistant |
| ENSG00000226445.1 |
Axitinib |
Sarcoma |
0.02356274 |
Resistant |
| ENSG00000227256.1 |
Axitinib |
Sarcoma |
0.035691468 |
Resistant |
| ENSG00000228748.2 |
Axitinib |
Sarcoma |
0.01070416 |
Resistant |
| ENSG00000229118.1 |
Axitinib |
Sarcoma |
0.002645021 |
Resistant |
| ENSG00000229388.1 |
Axitinib |
Sarcoma |
0.039857604 |
Resistant |
| ENSG00000229867.1 |
Axitinib |
Sarcoma |
0.043670269 |
Resistant |
| ENSG00000230082.1 |
Axitinib |
Sarcoma |
0.016408304 |
Resistant |
| ENSG00000230812.1 |
Axitinib |
Sarcoma |
0.020648871 |
Resistant |
| ENSG00000230825.1 |
Axitinib |
Sarcoma |
0.007082091 |
Resistant |
| ENSG00000232487.1 |
Axitinib |
Sarcoma |
0.021333882 |
Resistant |
| ENSG00000234494.3 |
Axitinib |
Sarcoma |
0.038002605 |
Resistant |
| ENSG00000235204.1 |
Axitinib |
Sarcoma |
0.020772052 |
Resistant |
| ENSG00000235852.1 |
Axitinib |
Sarcoma |
0.029538953 |
Resistant |
| ENSG00000237595.2 |
Axitinib |
Sarcoma |
0.006813421 |
Resistant |
| ENSG00000240093.1 |
Axitinib |
Sarcoma |
0.049009357 |
Resistant |
| ENSG00000240571.1 |
Axitinib |
Sarcoma |
0.039263913 |
Resistant |
| ENSG00000247311.2 |
Axitinib |
Sarcoma |
0.029202603 |
Resistant |
| ENSG00000250410.1 |
Axitinib |
Sarcoma |
0.047999417 |
Resistant |
| ENSG00000251141.1 |
Axitinib |
Sarcoma |
0.036341533 |
Resistant |
| ENSG00000251556.1 |
Axitinib |
Sarcoma |
0.024512615 |
Resistant |
| ENSG00000253167.1 |
Axitinib |
Sarcoma |
0.044225877 |
Resistant |
| ENSG00000253307.1 |
Axitinib |
Sarcoma |
0.004297388 |
Resistant |
| ENSG00000253837.1 |
Axitinib |
Sarcoma |
0.017595651 |
Resistant |
| ENSG00000254929.2 |
Axitinib |
Sarcoma |
0.040633479 |
Resistant |
| ENSG00000255409.1 |
Axitinib |
Sarcoma |
0.038545257 |
Resistant |
| ENSG00000259548.1 |
Axitinib |
Sarcoma |
0.021336819 |
Resistant |
| ENSG00000259659.1 |
Axitinib |
Sarcoma |
0.038951897 |
Resistant |
| ENSG00000260025.1 |
Axitinib |
Sarcoma |
0.031570255 |
Resistant |
| ENSG00000260417.1 |
Axitinib |
Sarcoma |
0.01293567 |
Resistant |
| ENSG00000260425.1 |
Axitinib |
Sarcoma |
0.02156082 |
Resistant |
| ENSG00000260572.1 |
Axitinib |
Sarcoma |
0.044155861 |
Resistant |
| ENSG00000260588.1 |
Axitinib |
Sarcoma |
0.040814205 |
Resistant |
| ENSG00000261490.1 |
Axitinib |
Sarcoma |
0.039565575 |
Resistant |
| ENSG00000261560.1 |
Axitinib |
Sarcoma |
0.010137011 |
Resistant |
| ENSG00000261610.1 |
Axitinib |
Sarcoma |
0.006346255 |
Resistant |
| ENSG00000262115.1 |
Axitinib |
Sarcoma |
0.023849585 |
Resistant |
| ENSG00000262171.1 |
Axitinib |
Sarcoma |
0.005669042 |
Resistant |
| ENSG00000263624.1 |
Axitinib |
Sarcoma |
0.030223457 |
Resistant |
| ENSG00000265205.1 |
Axitinib |
Sarcoma |
0.024307311 |
Resistant |
| ENSG00000265625.1 |
Axitinib |
Sarcoma |
0.049532454 |
Resistant |
| ENSG00000265933.1 |
Axitinib |
Sarcoma |
0.036087257 |
Resistant |
| ENSG00000266040.1 |
Axitinib |
Sarcoma |
0.008095727 |
Resistant |
| ENSG00000266947.1 |
Axitinib |
Sarcoma |
0.013790776 |
Resistant |
| ENSG00000267191.1 |
Axitinib |
Sarcoma |
0.014853467 |
Resistant |
| ENSG00000267758.1 |
Axitinib |
Sarcoma |
0.023996425 |
Resistant |
| ENSG00000270068.1 |
Axitinib |
Sarcoma |
0.015199643 |
Resistant |
| ENSG00000270346.1 |
Axitinib |
Sarcoma |
0.042500612 |
Resistant |
| ENSG00000270571.2 |
Axitinib |
Sarcoma |
0.034767073 |
Resistant |
| ENSG00000271991.1 |
Axitinib |
Sarcoma |
0.042779317 |
Resistant |
| ENSG00000272102.1 |
Axitinib |
Sarcoma |
0.048987064 |
Resistant |
| ENSG00000272620.1 |
Axitinib |
Sarcoma |
0.010826641 |
Resistant |
| ENSG00000272764.1 |
Axitinib |
Sarcoma |
0.01070344 |
Resistant |
| ENSG00000214432.5 |
Axitinib |
Skin cutaneous melanoma |
0.029417285 |
Resistant |
| ENSG00000223473.1 |
Axitinib |
Skin cutaneous melanoma |
0.018710704 |
Resistant |
| ENSG00000225146.1 |
Axitinib |
Skin cutaneous melanoma |
0.011128721 |
Resistant |
| ENSG00000225331.1 |
Axitinib |
Skin cutaneous melanoma |
0.005617666 |
Resistant |
| ENSG00000225334.1 |
Axitinib |
Skin cutaneous melanoma |
0.010524949 |
Resistant |
| ENSG00000225434.2 |
Axitinib |
Skin cutaneous melanoma |
0.045031993 |
Resistant |
| ENSG00000228686.2 |
Axitinib |
Skin cutaneous melanoma |
0.04428027 |
Resistant |
| ENSG00000230054.1 |
Axitinib |
Skin cutaneous melanoma |
0.015257148 |
Resistant |
| ENSG00000231509.1 |
Axitinib |
Skin cutaneous melanoma |
0.037146805 |
Resistant |
| ENSG00000231903.1 |
Axitinib |
Skin cutaneous melanoma |
0.008757276 |
Resistant |
| ENSG00000232043.1 |
Axitinib |
Skin cutaneous melanoma |
0.021139885 |
Resistant |
| ENSG00000232487.1 |
Axitinib |
Skin cutaneous melanoma |
0.003514918 |
Resistant |
| ENSG00000234006.1 |
Axitinib |
Skin cutaneous melanoma |
0.048022967 |
Resistant |
| ENSG00000234215.2 |
Axitinib |
Skin cutaneous melanoma |
0.013904186 |
Resistant |
| ENSG00000234676.1 |
Axitinib |
Skin cutaneous melanoma |
0.014420383 |
Resistant |
| ENSG00000235852.1 |
Axitinib |
Skin cutaneous melanoma |
0.040843865 |
Resistant |
| ENSG00000237310.1 |
Axitinib |
Skin cutaneous melanoma |
0.005304228 |
Resistant |
| ENSG00000239335.4 |
Axitinib |
Skin cutaneous melanoma |
0.043933755 |
Resistant |
| ENSG00000240770.1 |
Axitinib |
Skin cutaneous melanoma |
0.040677056 |
Resistant |
| ENSG00000244342.1 |
Axitinib |
Skin cutaneous melanoma |
0.032686923 |
Resistant |
| ENSG00000247199.3 |
Axitinib |
Skin cutaneous melanoma |
0.038988329 |
Resistant |
| ENSG00000247213.2 |
Axitinib |
Skin cutaneous melanoma |
0.023562719 |
Resistant |
| ENSG00000247708.3 |
Axitinib |
Skin cutaneous melanoma |
0.029150086 |
Resistant |
| ENSG00000249664.1 |
Axitinib |
Skin cutaneous melanoma |
0.035030921 |
Resistant |
| ENSG00000249791.1 |
Axitinib |
Skin cutaneous melanoma |
0.029651922 |
Resistant |
| ENSG00000249870.1 |
Axitinib |
Skin cutaneous melanoma |
0.026772153 |
Resistant |
| ENSG00000253284.2 |
Axitinib |
Skin cutaneous melanoma |
0.029950887 |
Resistant |
| ENSG00000253404.1 |
Axitinib |
Skin cutaneous melanoma |
0.009736498 |
Resistant |
| ENSG00000254129.1 |
Axitinib |
Skin cutaneous melanoma |
0.048678585 |
Resistant |
| ENSG00000254207.1 |
Axitinib |
Skin cutaneous melanoma |
0.021254035 |
Resistant |
| ENSG00000254295.1 |
Axitinib |
Skin cutaneous melanoma |
0.019375076 |
Resistant |
| ENSG00000254432.1 |
Axitinib |
Skin cutaneous melanoma |
0.02840212 |
Resistant |
| ENSG00000255348.1 |
Axitinib |
Skin cutaneous melanoma |
0.040794272 |
Resistant |
| ENSG00000256458.1 |
Axitinib |
Skin cutaneous melanoma |
0.008111395 |
Resistant |
| ENSG00000257004.1 |
Axitinib |
Skin cutaneous melanoma |
0.034252972 |
Resistant |
| ENSG00000257568.1 |
Axitinib |
Skin cutaneous melanoma |
0.041133031 |
Resistant |
| ENSG00000259768.3 |
Axitinib |
Skin cutaneous melanoma |
0.011497308 |
Resistant |
| ENSG00000260059.1 |
Axitinib |
Skin cutaneous melanoma |
0.028202073 |
Resistant |
| ENSG00000260439.1 |
Axitinib |
Skin cutaneous melanoma |
0.039449069 |
Resistant |
| ENSG00000260905.1 |
Axitinib |
Skin cutaneous melanoma |
0.021459046 |
Resistant |
| ENSG00000260973.1 |
Axitinib |
Skin cutaneous melanoma |
0.015714469 |
Resistant |
| ENSG00000261765.1 |
Axitinib |
Skin cutaneous melanoma |
0.047115769 |
Resistant |
| ENSG00000262652.1 |
Axitinib |
Skin cutaneous melanoma |
0.020691571 |
Resistant |
| ENSG00000263499.1 |
Axitinib |
Skin cutaneous melanoma |
0.03991676 |
Resistant |
| ENSG00000266850.1 |
Axitinib |
Skin cutaneous melanoma |
0.018326504 |
Resistant |
| ENSG00000267255.1 |
Axitinib |
Skin cutaneous melanoma |
0.010517993 |
Resistant |
| ENSG00000267454.1 |
Axitinib |
Skin cutaneous melanoma |
0.015362486 |
Resistant |
| ENSG00000267776.1 |
Axitinib |
Skin cutaneous melanoma |
0.019208364 |
Resistant |
| ENSG00000268499.1 |
Axitinib |
Skin cutaneous melanoma |
0.042961437 |
Resistant |
| ENSG00000269397.1 |
Axitinib |
Skin cutaneous melanoma |
0.030379663 |
Resistant |
| ENSG00000269524.1 |
Axitinib |
Skin cutaneous melanoma |
0.040869216 |
Resistant |
| ENSG00000271387.1 |
Axitinib |
Skin cutaneous melanoma |
0.042315138 |
Resistant |
| ENSG00000272002.1 |
Axitinib |
Skin cutaneous melanoma |
0.013544776 |
Resistant |
| ENSG00000272301.1 |
Axitinib |
Skin cutaneous melanoma |
0.049687524 |
Resistant |
| ENSG00000272425.1 |
Axitinib |
Skin cutaneous melanoma |
0.021408992 |
Resistant |
| ENSG00000272792.1 |
Axitinib |
Skin cutaneous melanoma |
0.011529691 |
Resistant |
| ENSG00000273365.1 |
Axitinib |
Skin cutaneous melanoma |
0.032225461 |
Resistant |
| ENSG00000273402.1 |
Axitinib |
Skin cutaneous melanoma |
0.021024471 |
Resistant |
| ENSG00000215068.3 |
Axitinib |
Bladder urothelial carcinoma |
0.023309092 |
Sensitive |
| ENSG00000221817.5 |
Axitinib |
Bladder urothelial carcinoma |
0.009484723 |
Sensitive |
| ENSG00000224079.1 |
Axitinib |
Bladder urothelial carcinoma |
0.044395558 |
Sensitive |
| ENSG00000225163.3 |
Axitinib |
Bladder urothelial carcinoma |
0.023912333 |
Sensitive |
| ENSG00000226445.1 |
Axitinib |
Bladder urothelial carcinoma |
0.002432409 |
Sensitive |
| ENSG00000226645.1 |
Axitinib |
Bladder urothelial carcinoma |
0.035179313 |
Sensitive |
| ENSG00000226851.1 |
Axitinib |
Bladder urothelial carcinoma |
0.020971806 |
Sensitive |
| ENSG00000229180.4 |
Axitinib |
Bladder urothelial carcinoma |
0.035713532 |
Sensitive |
| ENSG00000230658.1 |
Axitinib |
Bladder urothelial carcinoma |
0.014189054 |
Sensitive |
| ENSG00000232117.1 |
Axitinib |
Bladder urothelial carcinoma |
0.021304373 |
Sensitive |
| ENSG00000232295.3 |
Axitinib |
Bladder urothelial carcinoma |
0.000459702 |
Sensitive |
| ENSG00000234393.1 |
Axitinib |
Bladder urothelial carcinoma |
0.007125915 |
Sensitive |
| ENSG00000234449.2 |
Axitinib |
Bladder urothelial carcinoma |
0.014394654 |
Sensitive |
| ENSG00000235262.1 |
Axitinib |
Bladder urothelial carcinoma |
0.016635439 |
Sensitive |
| ENSG00000238287.1 |
Axitinib |
Bladder urothelial carcinoma |
0.048595371 |
Sensitive |
| ENSG00000242516.1 |
Axitinib |
Bladder urothelial carcinoma |
0.00159326 |
Sensitive |
| ENSG00000244265.1 |
Axitinib |
Bladder urothelial carcinoma |
0.037022722 |
Sensitive |
| ENSG00000248559.1 |
Axitinib |
Bladder urothelial carcinoma |
0.048582607 |
Sensitive |
| ENSG00000250320.1 |
Axitinib |
Bladder urothelial carcinoma |
0.036655475 |
Sensitive |
| ENSG00000250900.2 |
Axitinib |
Bladder urothelial carcinoma |
0.043438044 |
Sensitive |
| ENSG00000254027.1 |
Axitinib |
Bladder urothelial carcinoma |
0.023292973 |
Sensitive |
| ENSG00000254094.1 |
Axitinib |
Bladder urothelial carcinoma |
0.013617363 |
Sensitive |
| ENSG00000254560.1 |
Axitinib |
Bladder urothelial carcinoma |
0.014130964 |
Sensitive |
| ENSG00000254694.1 |
Axitinib |
Bladder urothelial carcinoma |
0.045337998 |
Sensitive |
| ENSG00000255843.1 |
Axitinib |
Bladder urothelial carcinoma |
0.012832278 |
Sensitive |
| ENSG00000256448.1 |
Axitinib |
Bladder urothelial carcinoma |
0.022686957 |
Sensitive |
| ENSG00000258667.1 |
Axitinib |
Bladder urothelial carcinoma |
0.044942151 |
Sensitive |
| ENSG00000258825.1 |
Axitinib |
Bladder urothelial carcinoma |
0.003402768 |
Sensitive |
| ENSG00000259583.1 |
Axitinib |
Bladder urothelial carcinoma |
0.027262191 |
Sensitive |
| ENSG00000260447.1 |
Axitinib |
Bladder urothelial carcinoma |
0.020920717 |
Sensitive |
| ENSG00000260635.1 |
Axitinib |
Bladder urothelial carcinoma |
0.044479294 |
Sensitive |
| ENSG00000261172.1 |
Axitinib |
Bladder urothelial carcinoma |
0.034462797 |
Sensitive |
| ENSG00000262202.3 |
Axitinib |
Bladder urothelial carcinoma |
0.024240442 |
Sensitive |
| ENSG00000264812.1 |
Axitinib |
Bladder urothelial carcinoma |
0.022117725 |
Sensitive |
| ENSG00000267289.1 |
Axitinib |
Bladder urothelial carcinoma |
0.015179971 |
Sensitive |
| ENSG00000267419.1 |
Axitinib |
Bladder urothelial carcinoma |
0.048049865 |
Sensitive |
| ENSG00000268015.1 |
Axitinib |
Bladder urothelial carcinoma |
0.014216546 |
Sensitive |
| ENSG00000270062.1 |
Axitinib |
Bladder urothelial carcinoma |
0.004379986 |
Sensitive |
| ENSG00000270189.1 |
Axitinib |
Bladder urothelial carcinoma |
0.013718542 |
Sensitive |
| ENSG00000271737.1 |
Axitinib |
Bladder urothelial carcinoma |
0.049003789 |
Sensitive |
| ENSG00000271778.1 |
Axitinib |
Bladder urothelial carcinoma |
0.026400909 |
Sensitive |
| ENSG00000271803.1 |
Axitinib |
Bladder urothelial carcinoma |
0.036367769 |
Sensitive |
| ENSG00000272144.1 |
Axitinib |
Bladder urothelial carcinoma |
0.03093699 |
Sensitive |
| ENSG00000272449.1 |
Axitinib |
Bladder urothelial carcinoma |
0.010241639 |
Sensitive |
| ENSG00000272452.1 |
Axitinib |
Bladder urothelial carcinoma |
0.02327694 |
Sensitive |
| ENSG00000272657.1 |
Axitinib |
Bladder urothelial carcinoma |
0.019744658 |
Sensitive |
| ENSG00000272834.1 |
Axitinib |
Bladder urothelial carcinoma |
0.034317443 |
Sensitive |
| ENSG00000273375.1 |
Axitinib |
Bladder urothelial carcinoma |
0.047807568 |
Sensitive |
| ENSG00000170919.11 |
Axitinib |
Breast invasive carcinoma |
0.005163507 |
Sensitive |
| ENSG00000178803.6 |
Axitinib |
Breast invasive carcinoma |
0.042612772 |
Sensitive |
| ENSG00000203325.3 |
Axitinib |
Breast invasive carcinoma |
0.005301247 |
Sensitive |
| ENSG00000204706.10 |
Axitinib |
Breast invasive carcinoma |
0.040997518 |
Sensitive |
| ENSG00000206142.5 |
Axitinib |
Breast invasive carcinoma |
0.043671932 |
Sensitive |
| ENSG00000212552.2 |
Axitinib |
Breast invasive carcinoma |
0.026013453 |
Sensitive |
| ENSG00000223522.1 |
Axitinib |
Breast invasive carcinoma |
0.00142103 |
Sensitive |
| ENSG00000223579.2 |
Axitinib |
Breast invasive carcinoma |
0.012086734 |
Sensitive |
| ENSG00000223598.1 |
Axitinib |
Breast invasive carcinoma |
0.021723012 |
Sensitive |
| ENSG00000223653.1 |
Axitinib |
Breast invasive carcinoma |
0.046029948 |
Sensitive |
| ENSG00000223695.1 |
Axitinib |
Breast invasive carcinoma |
0.014457589 |
Sensitive |
| ENSG00000224468.3 |
Axitinib |
Breast invasive carcinoma |
0.038936095 |
Sensitive |
| ENSG00000224635.1 |
Axitinib |
Breast invasive carcinoma |
0.049960464 |
Sensitive |
| ENSG00000224666.2 |
Axitinib |
Breast invasive carcinoma |
0.026316015 |
Sensitive |
| ENSG00000224844.1 |
Axitinib |
Breast invasive carcinoma |
0.046580618 |
Sensitive |
| ENSG00000224972.1 |
Axitinib |
Breast invasive carcinoma |
0.048308431 |
Sensitive |
| ENSG00000225075.1 |
Axitinib |
Breast invasive carcinoma |
0.045409842 |
Sensitive |
| ENSG00000225331.1 |
Axitinib |
Breast invasive carcinoma |
0.011490773 |
Sensitive |
| ENSG00000225434.2 |
Axitinib |
Breast invasive carcinoma |
0.014943726 |
Sensitive |
| ENSG00000225767.1 |
Axitinib |
Breast invasive carcinoma |
0.01178722 |
Sensitive |
| ENSG00000226746.2 |
Axitinib |
Breast invasive carcinoma |
0.013489934 |
Sensitive |
| ENSG00000226797.1 |
Axitinib |
Breast invasive carcinoma |
0.039880489 |
Sensitive |
| ENSG00000227698.1 |
Axitinib |
Breast invasive carcinoma |
0.008508255 |
Sensitive |
| ENSG00000227712.1 |
Axitinib |
Breast invasive carcinoma |
0.043618866 |
Sensitive |
| ENSG00000227741.1 |
Axitinib |
Breast invasive carcinoma |
0.009560924 |
Sensitive |
| ENSG00000227773.1 |
Axitinib |
Breast invasive carcinoma |
0.027111808 |
Sensitive |
| ENSG00000227811.2 |
Axitinib |
Breast invasive carcinoma |
0.048108801 |
Sensitive |
| ENSG00000228141.2 |
Axitinib |
Breast invasive carcinoma |
0.020021717 |
Sensitive |
| ENSG00000228237.1 |
Axitinib |
Breast invasive carcinoma |
0.006555753 |
Sensitive |
| ENSG00000229228.1 |
Axitinib |
Breast invasive carcinoma |
0.048339027 |
Sensitive |
| ENSG00000229431.1 |
Axitinib |
Breast invasive carcinoma |
0.031114034 |
Sensitive |
| ENSG00000229591.1 |
Axitinib |
Breast invasive carcinoma |
0.017508866 |
Sensitive |
| ENSG00000229688.3 |
Axitinib |
Breast invasive carcinoma |
0.03594231 |
Sensitive |
| ENSG00000231154.1 |
Axitinib |
Breast invasive carcinoma |
0.046406102 |
Sensitive |
| ENSG00000231611.1 |
Axitinib |
Breast invasive carcinoma |
0.008610179 |
Sensitive |
| ENSG00000231865.1 |
Axitinib |
Breast invasive carcinoma |
0.029083203 |
Sensitive |
| ENSG00000232077.1 |
Axitinib |
Breast invasive carcinoma |
0.043194986 |
Sensitive |
| ENSG00000232642.1 |
Axitinib |
Breast invasive carcinoma |
0.022746558 |
Sensitive |
| ENSG00000232650.1 |
Axitinib |
Breast invasive carcinoma |
0.049835003 |
Sensitive |
| ENSG00000233207.1 |
Axitinib |
Breast invasive carcinoma |
0.019356762 |
Sensitive |
| ENSG00000234740.1 |
Axitinib |
Breast invasive carcinoma |
0.034954216 |
Sensitive |
| ENSG00000235358.1 |
Axitinib |
Breast invasive carcinoma |
0.013904809 |
Sensitive |
| ENSG00000235635.1 |
Axitinib |
Breast invasive carcinoma |
0.039707798 |
Sensitive |
| ENSG00000235910.1 |
Axitinib |
Breast invasive carcinoma |
0.024842323 |
Sensitive |
| ENSG00000236404.4 |
Axitinib |
Breast invasive carcinoma |
0.013795656 |
Sensitive |
| ENSG00000236935.1 |
Axitinib |
Breast invasive carcinoma |
0.037217843 |
Sensitive |
| ENSG00000237604.1 |
Axitinib |
Breast invasive carcinoma |
0.029214915 |
Sensitive |
| ENSG00000237721.1 |
Axitinib |
Breast invasive carcinoma |
0.013517665 |
Sensitive |
| ENSG00000237836.1 |
Axitinib |
Breast invasive carcinoma |
0.041968318 |
Sensitive |
| ENSG00000237938.1 |
Axitinib |
Breast invasive carcinoma |
0.026613686 |
Sensitive |
| ENSG00000238045.5 |
Axitinib |
Breast invasive carcinoma |
0.024407803 |
Sensitive |
| ENSG00000238198.1 |
Axitinib |
Breast invasive carcinoma |
0.020185948 |
Sensitive |
| ENSG00000239653.1 |
Axitinib |
Breast invasive carcinoma |
0.038724693 |
Sensitive |
| ENSG00000239801.1 |
Axitinib |
Breast invasive carcinoma |
0.038014619 |
Sensitive |
| ENSG00000240057.1 |
Axitinib |
Breast invasive carcinoma |
0.045982138 |
Sensitive |
| ENSG00000241014.1 |
Axitinib |
Breast invasive carcinoma |
0.023545544 |
Sensitive |
| ENSG00000244055.1 |
Axitinib |
Breast invasive carcinoma |
0.032636792 |
Sensitive |
| ENSG00000244327.1 |
Axitinib |
Breast invasive carcinoma |
0.005098947 |
Sensitive |
| ENSG00000246334.2 |
Axitinib |
Breast invasive carcinoma |
0.026564939 |
Sensitive |
| ENSG00000246859.2 |
Axitinib |
Breast invasive carcinoma |
0.048888951 |
Sensitive |
| ENSG00000248559.1 |
Axitinib |
Breast invasive carcinoma |
0.015021369 |
Sensitive |
| ENSG00000248664.1 |
Axitinib |
Breast invasive carcinoma |
0.032886808 |
Sensitive |
| ENSG00000249532.2 |
Axitinib |
Breast invasive carcinoma |
0.014058127 |
Sensitive |
| ENSG00000251194.2 |
Axitinib |
Breast invasive carcinoma |
0.034124834 |
Sensitive |
| ENSG00000253476.1 |
Axitinib |
Breast invasive carcinoma |
0.03078875 |
Sensitive |
| ENSG00000254694.1 |
Axitinib |
Breast invasive carcinoma |
0.03132871 |
Sensitive |
| ENSG00000254846.1 |
Axitinib |
Breast invasive carcinoma |
0.049635239 |
Sensitive |
| ENSG00000254855.1 |
Axitinib |
Breast invasive carcinoma |
0.013379718 |
Sensitive |
| ENSG00000255176.1 |
Axitinib |
Breast invasive carcinoma |
0.007357824 |
Sensitive |
| ENSG00000255343.1 |
Axitinib |
Breast invasive carcinoma |
0.010505655 |
Sensitive |
| ENSG00000255443.1 |
Axitinib |
Breast invasive carcinoma |
0.048316498 |
Sensitive |
| ENSG00000256967.1 |
Axitinib |
Breast invasive carcinoma |
0.04962389 |
Sensitive |
| ENSG00000257221.1 |
Axitinib |
Breast invasive carcinoma |
0.048925138 |
Sensitive |
| ENSG00000257279.1 |
Axitinib |
Breast invasive carcinoma |
0.029058856 |
Sensitive |
| ENSG00000257381.2 |
Axitinib |
Breast invasive carcinoma |
0.043054334 |
Sensitive |
| ENSG00000257556.1 |
Axitinib |
Breast invasive carcinoma |
0.043880496 |
Sensitive |
| ENSG00000257931.2 |
Axitinib |
Breast invasive carcinoma |
0.01348037 |
Sensitive |
| ENSG00000258314.2 |
Axitinib |
Breast invasive carcinoma |
0.031419849 |
Sensitive |
| ENSG00000258754.3 |
Axitinib |
Breast invasive carcinoma |
0.045848072 |
Sensitive |
| ENSG00000258959.1 |
Axitinib |
Breast invasive carcinoma |
0.026316771 |
Sensitive |
| ENSG00000259138.1 |
Axitinib |
Breast invasive carcinoma |
0.046329679 |
Sensitive |
| ENSG00000259287.1 |
Axitinib |
Breast invasive carcinoma |
0.039775485 |
Sensitive |
| ENSG00000259408.1 |
Axitinib |
Breast invasive carcinoma |
0.024368507 |
Sensitive |
| ENSG00000259590.1 |
Axitinib |
Breast invasive carcinoma |
0.038700465 |
Sensitive |
| ENSG00000259652.1 |
Axitinib |
Breast invasive carcinoma |
0.008100391 |
Sensitive |
| ENSG00000259774.1 |
Axitinib |
Breast invasive carcinoma |
0.026934512 |
Sensitive |
| ENSG00000259863.1 |
Axitinib |
Breast invasive carcinoma |
0.044046574 |
Sensitive |
| ENSG00000260005.2 |
Axitinib |
Breast invasive carcinoma |
0.041799747 |
Sensitive |
| ENSG00000260037.1 |
Axitinib |
Breast invasive carcinoma |
0.003184973 |
Sensitive |
| ENSG00000260179.1 |
Axitinib |
Breast invasive carcinoma |
0.017926368 |
Sensitive |
| ENSG00000260277.1 |
Axitinib |
Breast invasive carcinoma |
0.026743451 |
Sensitive |
| ENSG00000260367.1 |
Axitinib |
Breast invasive carcinoma |
0.033096294 |
Sensitive |
| ENSG00000260517.1 |
Axitinib |
Breast invasive carcinoma |
0.016619255 |
Sensitive |
| ENSG00000260536.1 |
Axitinib |
Breast invasive carcinoma |
0.04778843 |
Sensitive |
| ENSG00000260626.1 |
Axitinib |
Breast invasive carcinoma |
0.025362632 |
Sensitive |
| ENSG00000260938.1 |
Axitinib |
Breast invasive carcinoma |
0.027392504 |
Sensitive |
| ENSG00000260978.1 |
Axitinib |
Breast invasive carcinoma |
0.033477363 |
Sensitive |
| ENSG00000261070.1 |
Axitinib |
Breast invasive carcinoma |
0.044519295 |
Sensitive |
| ENSG00000261117.1 |
Axitinib |
Breast invasive carcinoma |
0.038181264 |
Sensitive |
| ENSG00000261254.1 |
Axitinib |
Breast invasive carcinoma |
0.012816303 |
Sensitive |
| ENSG00000262313.1 |
Axitinib |
Breast invasive carcinoma |
0.016675278 |
Sensitive |
| ENSG00000262434.1 |
Axitinib |
Breast invasive carcinoma |
0.027026498 |
Sensitive |
| ENSG00000262905.1 |
Axitinib |
Breast invasive carcinoma |
0.029643619 |
Sensitive |
| ENSG00000263388.1 |
Axitinib |
Breast invasive carcinoma |
0.030346252 |
Sensitive |
| ENSG00000263916.1 |
Axitinib |
Breast invasive carcinoma |
0.02026716 |
Sensitive |
| ENSG00000264167.1 |
Axitinib |
Breast invasive carcinoma |
0.039424543 |
Sensitive |
| ENSG00000264860.1 |
Axitinib |
Breast invasive carcinoma |
0.035220829 |
Sensitive |
| ENSG00000264937.1 |
Axitinib |
Breast invasive carcinoma |
0.03064334 |
Sensitive |
| ENSG00000265010.1 |
Axitinib |
Breast invasive carcinoma |
0.039290366 |
Sensitive |
| ENSG00000265511.1 |
Axitinib |
Breast invasive carcinoma |
0.008726839 |
Sensitive |
| ENSG00000266010.1 |
Axitinib |
Breast invasive carcinoma |
0.037876677 |
Sensitive |
| ENSG00000266651.1 |
Axitinib |
Breast invasive carcinoma |
0.001148151 |
Sensitive |
| ENSG00000266897.1 |
Axitinib |
Breast invasive carcinoma |
0.014711362 |
Sensitive |
| ENSG00000266975.1 |
Axitinib |
Breast invasive carcinoma |
0.010934671 |
Sensitive |
| ENSG00000267758.1 |
Axitinib |
Breast invasive carcinoma |
0.035105912 |
Sensitive |
| ENSG00000267919.1 |
Axitinib |
Breast invasive carcinoma |
0.007058164 |
Sensitive |
| ENSG00000269956.1 |
Axitinib |
Breast invasive carcinoma |
0.03058993 |
Sensitive |
| ENSG00000270022.2 |
Axitinib |
Breast invasive carcinoma |
0.009939468 |
Sensitive |
| ENSG00000270031.1 |
Axitinib |
Breast invasive carcinoma |
0.008606794 |
Sensitive |
| ENSG00000270110.1 |
Axitinib |
Breast invasive carcinoma |
0.040140491 |
Sensitive |
| ENSG00000271308.1 |
Axitinib |
Breast invasive carcinoma |
0.041739454 |
Sensitive |
| ENSG00000271554.1 |
Axitinib |
Breast invasive carcinoma |
0.010544893 |
Sensitive |
| ENSG00000272512.1 |
Axitinib |
Breast invasive carcinoma |
0.037918348 |
Sensitive |
| ENSG00000272524.1 |
Axitinib |
Breast invasive carcinoma |
0.019423358 |
Sensitive |
| ENSG00000272537.1 |
Axitinib |
Breast invasive carcinoma |
0.008545865 |
Sensitive |
| ENSG00000272576.1 |
Axitinib |
Breast invasive carcinoma |
0.037133757 |
Sensitive |
| ENSG00000272644.1 |
Axitinib |
Breast invasive carcinoma |
0.008168011 |
Sensitive |
| ENSG00000272689.1 |
Axitinib |
Breast invasive carcinoma |
0.028983968 |
Sensitive |
| ENSG00000272870.1 |
Axitinib |
Breast invasive carcinoma |
0.02127918 |
Sensitive |
| ENSG00000272977.1 |
Axitinib |
Breast invasive carcinoma |
0.010109198 |
Sensitive |
| ENSG00000273014.1 |
Axitinib |
Breast invasive carcinoma |
0.029088367 |
Sensitive |
| ENSG00000273302.1 |
Axitinib |
Breast invasive carcinoma |
0.000198171 |
Sensitive |
| ENSG00000273350.1 |
Axitinib |
Breast invasive carcinoma |
0.008526309 |
Sensitive |
| ENSG00000273353.1 |
Axitinib |
Breast invasive carcinoma |
0.04404783 |
Sensitive |
| ENSG00000273428.1 |
Axitinib |
Breast invasive carcinoma |
0.014101025 |
Sensitive |
| ENSG00000273442.1 |
Axitinib |
Breast invasive carcinoma |
0.030919052 |
Sensitive |
| ENSG00000125804.9 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026878856 |
Sensitive |
| ENSG00000177757.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035006273 |
Sensitive |
| ENSG00000197813.4 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040606317 |
Sensitive |
| ENSG00000204791.4 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014678954 |
Sensitive |
| ENSG00000215394.4 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013895034 |
Sensitive |
| ENSG00000223576.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032268514 |
Sensitive |
| ENSG00000223714.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001821853 |
Sensitive |
| ENSG00000224050.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030430213 |
Sensitive |
| ENSG00000225030.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045458606 |
Sensitive |
| ENSG00000225439.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035979119 |
Sensitive |
| ENSG00000226029.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045171224 |
Sensitive |
| ENSG00000226352.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037571324 |
Sensitive |
| ENSG00000227492.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032484815 |
Sensitive |
| ENSG00000227502.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002980838 |
Sensitive |
| ENSG00000227740.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033916608 |
Sensitive |
| ENSG00000227773.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04062224 |
Sensitive |
| ENSG00000227953.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006318421 |
Sensitive |
| ENSG00000228010.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03622769 |
Sensitive |
| ENSG00000228237.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04797456 |
Sensitive |
| ENSG00000228389.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040508955 |
Sensitive |
| ENSG00000228763.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.011665195 |
Sensitive |
| ENSG00000228839.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017745494 |
Sensitive |
| ENSG00000228889.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045971765 |
Sensitive |
| ENSG00000229702.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005281378 |
Sensitive |
| ENSG00000230310.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042328484 |
Sensitive |
| ENSG00000230565.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03052609 |
Sensitive |
| ENSG00000231595.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041579986 |
Sensitive |
| ENSG00000231636.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030376601 |
Sensitive |
| ENSG00000231944.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017959613 |
Sensitive |
| ENSG00000232729.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032934211 |
Sensitive |
| ENSG00000232931.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035541238 |
Sensitive |
| ENSG00000233061.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04428381 |
Sensitive |
| ENSG00000233783.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.012436347 |
Sensitive |
| ENSG00000234290.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048672096 |
Sensitive |
| ENSG00000234665.4 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040407066 |
Sensitive |
| ENSG00000234818.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038974317 |
Sensitive |
| ENSG00000234945.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032041554 |
Sensitive |
| ENSG00000234996.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013432192 |
Sensitive |
| ENSG00000235908.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008997293 |
Sensitive |
| ENSG00000236199.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024023807 |
Sensitive |
| ENSG00000237017.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028736311 |
Sensitive |
| ENSG00000237903.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008356707 |
Sensitive |
| ENSG00000238018.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02744572 |
Sensitive |
| ENSG00000240549.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042250444 |
Sensitive |
| ENSG00000242798.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023692941 |
Sensitive |
| ENSG00000244393.3 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015072499 |
Sensitive |
| ENSG00000245748.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009194313 |
Sensitive |
| ENSG00000248175.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015026425 |
Sensitive |
| ENSG00000249456.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005890213 |
Sensitive |
| ENSG00000249635.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035802519 |
Sensitive |
| ENSG00000250295.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04682593 |
Sensitive |
| ENSG00000250909.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013139067 |
Sensitive |
| ENSG00000251175.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017215137 |
Sensitive |
| ENSG00000251580.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027315556 |
Sensitive |
| ENSG00000253307.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015071245 |
Sensitive |
| ENSG00000253392.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040918233 |
Sensitive |
| ENSG00000253399.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017193835 |
Sensitive |
| ENSG00000254263.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041524418 |
Sensitive |
| ENSG00000255487.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023193619 |
Sensitive |
| ENSG00000256116.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004296255 |
Sensitive |
| ENSG00000256603.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048080915 |
Sensitive |
| ENSG00000258355.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016590718 |
Sensitive |
| ENSG00000258682.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047886066 |
Sensitive |
| ENSG00000258725.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045080605 |
Sensitive |
| ENSG00000259322.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017660527 |
Sensitive |
| ENSG00000259595.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001109573 |
Sensitive |
| ENSG00000259758.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049238558 |
Sensitive |
| ENSG00000259806.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025275889 |
Sensitive |
| ENSG00000260213.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022773518 |
Sensitive |
| ENSG00000260400.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00040818 |
Sensitive |
| ENSG00000260565.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046544909 |
Sensitive |
| ENSG00000260917.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02610424 |
Sensitive |
| ENSG00000261002.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029194934 |
Sensitive |
| ENSG00000261064.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042706854 |
Sensitive |
| ENSG00000261267.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01474338 |
Sensitive |
| ENSG00000261337.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034063972 |
Sensitive |
| ENSG00000263470.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024791157 |
Sensitive |
| ENSG00000263727.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00871932 |
Sensitive |
| ENSG00000264167.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042276399 |
Sensitive |
| ENSG00000264469.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032654116 |
Sensitive |
| ENSG00000264937.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001500094 |
Sensitive |
| ENSG00000266236.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.012857522 |
Sensitive |
| ENSG00000266717.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049385316 |
Sensitive |
| ENSG00000267108.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003699838 |
Sensitive |
| ENSG00000267117.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005626672 |
Sensitive |
| ENSG00000267491.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045437236 |
Sensitive |
| ENSG00000267778.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013489982 |
Sensitive |
| ENSG00000267940.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013392814 |
Sensitive |
| ENSG00000268006.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034178116 |
Sensitive |
| ENSG00000268081.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040105361 |
Sensitive |
| ENSG00000269044.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041314945 |
Sensitive |
| ENSG00000269290.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039585696 |
Sensitive |
| ENSG00000269707.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016336783 |
Sensitive |
| ENSG00000269910.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035636347 |
Sensitive |
| ENSG00000269940.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024663975 |
Sensitive |
| ENSG00000269947.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027193586 |
Sensitive |
| ENSG00000269951.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036336736 |
Sensitive |
| ENSG00000269958.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044294614 |
Sensitive |
| ENSG00000269959.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023666635 |
Sensitive |
| ENSG00000270006.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049469326 |
Sensitive |
| ENSG00000270028.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033725635 |
Sensitive |
| ENSG00000270062.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.0011949 |
Sensitive |
| ENSG00000270083.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036882753 |
Sensitive |
| ENSG00000270140.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040710362 |
Sensitive |
| ENSG00000270184.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04072224 |
Sensitive |
| ENSG00000270580.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015704483 |
Sensitive |
| ENSG00000271228.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046942293 |
Sensitive |
| ENSG00000271533.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000604645 |
Sensitive |
| ENSG00000271554.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015847522 |
Sensitive |
| ENSG00000271843.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03907219 |
Sensitive |
| ENSG00000271851.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013543923 |
Sensitive |
| ENSG00000272040.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033465238 |
Sensitive |
| ENSG00000272077.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041934984 |
Sensitive |
| ENSG00000272148.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046920572 |
Sensitive |
| ENSG00000272250.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007281516 |
Sensitive |
| ENSG00000272520.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026990232 |
Sensitive |
| ENSG00000272696.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034214361 |
Sensitive |
| ENSG00000272764.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034022212 |
Sensitive |
| ENSG00000272888.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040480379 |
Sensitive |
| ENSG00000273007.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048734308 |
Sensitive |
| ENSG00000273203.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049577646 |
Sensitive |
| ENSG00000273302.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01126162 |
Sensitive |
| ENSG00000273343.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.011056508 |
Sensitive |
| ENSG00000273353.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00320396 |
Sensitive |
| ENSG00000273447.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043271371 |
Sensitive |
| ENSG00000203496.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045943472 |
Sensitive |
| ENSG00000237187.4 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034962796 |
Sensitive |
| ENSG00000245750.3 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032750465 |
Sensitive |
| ENSG00000271086.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028883813 |
Sensitive |
| ENSG00000175701.6 |
Axitinib |
Esophageal cancer |
0.012640897 |
Sensitive |
| ENSG00000223478.1 |
Axitinib |
Esophageal cancer |
0.024429059 |
Sensitive |
| ENSG00000223749.3 |
Axitinib |
Esophageal cancer |
0.02482166 |
Sensitive |
| ENSG00000224592.1 |
Axitinib |
Esophageal cancer |
0.001474546 |
Sensitive |
| ENSG00000224635.1 |
Axitinib |
Esophageal cancer |
0.022169493 |
Sensitive |
| ENSG00000224985.1 |
Axitinib |
Esophageal cancer |
0.023372693 |
Sensitive |
| ENSG00000226172.2 |
Axitinib |
Esophageal cancer |
0.023506956 |
Sensitive |
| ENSG00000227193.2 |
Axitinib |
Esophageal cancer |
0.003268748 |
Sensitive |
| ENSG00000227477.1 |
Axitinib |
Esophageal cancer |
0.02453517 |
Sensitive |
| ENSG00000228526.2 |
Axitinib |
Esophageal cancer |
0.000714473 |
Sensitive |
| ENSG00000231829.2 |
Axitinib |
Esophageal cancer |
0.004752797 |
Sensitive |
| ENSG00000231966.1 |
Axitinib |
Esophageal cancer |
0.013991836 |
Sensitive |
| ENSG00000232386.5 |
Axitinib |
Esophageal cancer |
0.0000278 |
Sensitive |
| ENSG00000233695.1 |
Axitinib |
Esophageal cancer |
0.020947243 |
Sensitive |
| ENSG00000234026.1 |
Axitinib |
Esophageal cancer |
0.032541924 |
Sensitive |
| ENSG00000234546.2 |
Axitinib |
Esophageal cancer |
0.0000935 |
Sensitive |
| ENSG00000234913.1 |
Axitinib |
Esophageal cancer |
0.003624608 |
Sensitive |
| ENSG00000235066.4 |
Axitinib |
Esophageal cancer |
0.036185811 |
Sensitive |
| ENSG00000235837.1 |
Axitinib |
Esophageal cancer |
0.02303639 |
Sensitive |
| ENSG00000236095.1 |
Axitinib |
Esophageal cancer |
0.035345826 |
Sensitive |
| ENSG00000236200.1 |
Axitinib |
Esophageal cancer |
0.046392303 |
Sensitive |
| ENSG00000236269.1 |
Axitinib |
Esophageal cancer |
0.002806114 |
Sensitive |
| ENSG00000236333.3 |
Axitinib |
Esophageal cancer |
0.017122169 |
Sensitive |
| ENSG00000236510.1 |
Axitinib |
Esophageal cancer |
0.001679699 |
Sensitive |
| ENSG00000236528.1 |
Axitinib |
Esophageal cancer |
0.017448496 |
Sensitive |
| ENSG00000237697.2 |
Axitinib |
Esophageal cancer |
0.001593438 |
Sensitive |
| ENSG00000237805.1 |
Axitinib |
Esophageal cancer |
0.0384251 |
Sensitive |
| ENSG00000240373.1 |
Axitinib |
Esophageal cancer |
0.005547727 |
Sensitive |
| ENSG00000242012.1 |
Axitinib |
Esophageal cancer |
0.014686965 |
Sensitive |
| ENSG00000244968.2 |
Axitinib |
Esophageal cancer |
0.034921106 |
Sensitive |
| ENSG00000247516.3 |
Axitinib |
Esophageal cancer |
0.045633076 |
Sensitive |
| ENSG00000249532.2 |
Axitinib |
Esophageal cancer |
0.026584656 |
Sensitive |
| ENSG00000253372.1 |
Axitinib |
Esophageal cancer |
0.011699491 |
Sensitive |
| ENSG00000254162.1 |
Axitinib |
Esophageal cancer |
0.034215789 |
Sensitive |
| ENSG00000254664.1 |
Axitinib |
Esophageal cancer |
0.039872967 |
Sensitive |
| ENSG00000255020.1 |
Axitinib |
Esophageal cancer |
0.018477782 |
Sensitive |
| ENSG00000256443.1 |
Axitinib |
Esophageal cancer |
0.004411051 |
Sensitive |
| ENSG00000259039.1 |
Axitinib |
Esophageal cancer |
0.03007036 |
Sensitive |
| ENSG00000259343.1 |
Axitinib |
Esophageal cancer |
0.044688158 |
Sensitive |
| ENSG00000259364.1 |
Axitinib |
Esophageal cancer |
0.041585531 |
Sensitive |
| ENSG00000259792.1 |
Axitinib |
Esophageal cancer |
0.046933739 |
Sensitive |
| ENSG00000260194.1 |
Axitinib |
Esophageal cancer |
0.034999254 |
Sensitive |
| ENSG00000261024.2 |
Axitinib |
Esophageal cancer |
0.045546623 |
Sensitive |
| ENSG00000261092.1 |
Axitinib |
Esophageal cancer |
0.014748055 |
Sensitive |
| ENSG00000261353.1 |
Axitinib |
Esophageal cancer |
0.017933756 |
Sensitive |
| ENSG00000264012.1 |
Axitinib |
Esophageal cancer |
0.030350639 |
Sensitive |
| ENSG00000266371.1 |
Axitinib |
Esophageal cancer |
0.02671381 |
Sensitive |
| ENSG00000266709.1 |
Axitinib |
Esophageal cancer |
0.032228329 |
Sensitive |
| ENSG00000266993.1 |
Axitinib |
Esophageal cancer |
0.014994714 |
Sensitive |
| ENSG00000267280.1 |
Axitinib |
Esophageal cancer |
0.00247693 |
Sensitive |
| ENSG00000268895.1 |
Axitinib |
Esophageal cancer |
0.002502854 |
Sensitive |
| ENSG00000269148.1 |
Axitinib |
Esophageal cancer |
0.020953957 |
Sensitive |
| ENSG00000269901.1 |
Axitinib |
Esophageal cancer |
0.042992907 |
Sensitive |
| ENSG00000269962.1 |
Axitinib |
Esophageal cancer |
0.01739383 |
Sensitive |
| ENSG00000271554.1 |
Axitinib |
Esophageal cancer |
0.021133139 |
Sensitive |
| ENSG00000271964.1 |
Axitinib |
Esophageal cancer |
0.001441552 |
Sensitive |
| ENSG00000272264.1 |
Axitinib |
Esophageal cancer |
0.016040235 |
Sensitive |
| ENSG00000272808.1 |
Axitinib |
Esophageal cancer |
0.015110893 |
Sensitive |
| ENSG00000273125.1 |
Axitinib |
Esophageal cancer |
0.021077326 |
Sensitive |
| ENSG00000273474.1 |
Axitinib |
Esophageal cancer |
0.027218919 |
Sensitive |
| ENSG00000172250.10 |
Axitinib |
Head and neck squamous cell carcinoma |
0.033399056 |
Sensitive |
| ENSG00000205037.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.028359223 |
Sensitive |
| ENSG00000224116.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.019074993 |
Sensitive |
| ENSG00000225361.3 |
Axitinib |
Head and neck squamous cell carcinoma |
0.040986291 |
Sensitive |
| ENSG00000225760.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.022071462 |
Sensitive |
| ENSG00000226609.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.034602164 |
Sensitive |
| ENSG00000226746.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.003090351 |
Sensitive |
| ENSG00000227354.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.038765621 |
Sensitive |
| ENSG00000227606.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.037234443 |
Sensitive |
| ENSG00000228639.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.011458138 |
Sensitive |
| ENSG00000228789.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.021559117 |
Sensitive |
| ENSG00000228918.3 |
Axitinib |
Head and neck squamous cell carcinoma |
0.031269226 |
Sensitive |
| ENSG00000231711.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.047533283 |
Sensitive |
| ENSG00000232233.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.027267092 |
Sensitive |
| ENSG00000233221.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.005103609 |
Sensitive |
| ENSG00000233237.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.028407878 |
Sensitive |
| ENSG00000233246.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.003075165 |
Sensitive |
| ENSG00000234350.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.026723643 |
Sensitive |
| ENSG00000235078.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.033862832 |
Sensitive |
| ENSG00000235954.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.012340786 |
Sensitive |
| ENSG00000236438.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.031561091 |
Sensitive |
| ENSG00000237588.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.009495979 |
Sensitive |
| ENSG00000237689.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.037602189 |
Sensitive |
| ENSG00000238107.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.019274012 |
Sensitive |
| ENSG00000239636.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.0216461 |
Sensitive |
| ENSG00000242687.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.04544252 |
Sensitive |
| ENSG00000244252.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.01869974 |
Sensitive |
| ENSG00000245534.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.037021336 |
Sensitive |
| ENSG00000249825.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.03296993 |
Sensitive |
| ENSG00000251143.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.044990583 |
Sensitive |
| ENSG00000251175.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.01456785 |
Sensitive |
| ENSG00000253508.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.047617066 |
Sensitive |
| ENSG00000253595.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.020767176 |
Sensitive |
| ENSG00000255495.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.036594161 |
Sensitive |
| ENSG00000257496.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.023222648 |
Sensitive |
| ENSG00000258301.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.025641595 |
Sensitive |
| ENSG00000258789.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.003015197 |
Sensitive |
| ENSG00000259407.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.003834003 |
Sensitive |
| ENSG00000259417.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.045699003 |
Sensitive |
| ENSG00000259453.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.004287684 |
Sensitive |
| ENSG00000260475.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.041820376 |
Sensitive |
| ENSG00000260586.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.046905733 |
Sensitive |
| ENSG00000260630.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.016375959 |
Sensitive |
| ENSG00000260646.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.044692876 |
Sensitive |
| ENSG00000260831.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.019076865 |
Sensitive |
| ENSG00000260874.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.003887404 |
Sensitive |
| ENSG00000260948.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.033220805 |
Sensitive |
| ENSG00000261338.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.004833677 |
Sensitive |
| ENSG00000261924.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.038906519 |
Sensitive |
| ENSG00000266283.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.007700849 |
Sensitive |
| ENSG00000270020.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.004061348 |
Sensitive |
| ENSG00000270022.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.046792858 |
Sensitive |
| ENSG00000270105.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.006954901 |
Sensitive |
| ENSG00000270143.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.004783691 |
Sensitive |
| ENSG00000272068.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.011186181 |
Sensitive |
| ENSG00000272112.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.02733589 |
Sensitive |
| ENSG00000272141.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.007669427 |
Sensitive |
| ENSG00000272180.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.021606414 |
Sensitive |
| ENSG00000177993.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.0354903 |
Sensitive |
| ENSG00000215869.3 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016755336 |
Sensitive |
| ENSG00000229154.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01706096 |
Sensitive |
| ENSG00000231628.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.02683012 |
Sensitive |
| ENSG00000234149.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.04554986 |
Sensitive |
| ENSG00000236115.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.049122982 |
Sensitive |
| ENSG00000250295.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.037770823 |
Sensitive |
| ENSG00000253106.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023987232 |
Sensitive |
| ENSG00000253754.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.016825681 |
Sensitive |
| ENSG00000255443.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.023553666 |
Sensitive |
| ENSG00000262873.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.012943974 |
Sensitive |
| ENSG00000265094.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.028274926 |
Sensitive |
| ENSG00000266717.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.040521948 |
Sensitive |
| ENSG00000270069.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001848934 |
Sensitive |
| ENSG00000125804.9 |
Axitinib |
Brain lower grade glioma |
0.021022853 |
Sensitive |
| ENSG00000231908.1 |
Axitinib |
Brain lower grade glioma |
0.044387997 |
Sensitive |
| ENSG00000243479.3 |
Axitinib |
Brain lower grade glioma |
0.038556759 |
Sensitive |
| ENSG00000248537.1 |
Axitinib |
Brain lower grade glioma |
0.039024721 |
Sensitive |
| ENSG00000251577.1 |
Axitinib |
Brain lower grade glioma |
0.046356618 |
Sensitive |
| ENSG00000256576.1 |
Axitinib |
Brain lower grade glioma |
0.042096683 |
Sensitive |
| ENSG00000258274.1 |
Axitinib |
Brain lower grade glioma |
0.034170265 |
Sensitive |
| ENSG00000264673.1 |
Axitinib |
Brain lower grade glioma |
0.035403025 |
Sensitive |
| ENSG00000266441.1 |
Axitinib |
Brain lower grade glioma |
0.002633702 |
Sensitive |
| ENSG00000267662.1 |
Axitinib |
Brain lower grade glioma |
0.045167187 |
Sensitive |
| ENSG00000271732.1 |
Axitinib |
Brain lower grade glioma |
0.039717049 |
Sensitive |
| ENSG00000183242.7 |
Axitinib |
Lung squamous cell carcinoma |
0.036997485 |
Sensitive |
| ENSG00000203307.2 |
Axitinib |
Lung squamous cell carcinoma |
0.020154962 |
Sensitive |
| ENSG00000203362.2 |
Axitinib |
Lung squamous cell carcinoma |
0.020099838 |
Sensitive |
| ENSG00000224222.1 |
Axitinib |
Lung squamous cell carcinoma |
0.042325286 |
Sensitive |
| ENSG00000224707.1 |
Axitinib |
Lung squamous cell carcinoma |
0.029795744 |
Sensitive |
| ENSG00000225180.2 |
Axitinib |
Lung squamous cell carcinoma |
0.01497448 |
Sensitive |
| ENSG00000226562.2 |
Axitinib |
Lung squamous cell carcinoma |
0.034062376 |
Sensitive |
| ENSG00000226890.1 |
Axitinib |
Lung squamous cell carcinoma |
0.034692406 |
Sensitive |
| ENSG00000226920.1 |
Axitinib |
Lung squamous cell carcinoma |
0.028334529 |
Sensitive |
| ENSG00000227285.1 |
Axitinib |
Lung squamous cell carcinoma |
0.04655456 |
Sensitive |
| ENSG00000227741.1 |
Axitinib |
Lung squamous cell carcinoma |
0.009771286 |
Sensitive |
| ENSG00000228127.1 |
Axitinib |
Lung squamous cell carcinoma |
0.035530447 |
Sensitive |
| ENSG00000228677.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040322954 |
Sensitive |
| ENSG00000230289.1 |
Axitinib |
Lung squamous cell carcinoma |
0.020093709 |
Sensitive |
| ENSG00000230314.2 |
Axitinib |
Lung squamous cell carcinoma |
0.047036356 |
Sensitive |
| ENSG00000230699.2 |
Axitinib |
Lung squamous cell carcinoma |
0.027573879 |
Sensitive |
| ENSG00000230736.2 |
Axitinib |
Lung squamous cell carcinoma |
0.04992334 |
Sensitive |
| ENSG00000231305.3 |
Axitinib |
Lung squamous cell carcinoma |
0.044786942 |
Sensitive |
| ENSG00000232224.1 |
Axitinib |
Lung squamous cell carcinoma |
0.024409518 |
Sensitive |
| ENSG00000232611.1 |
Axitinib |
Lung squamous cell carcinoma |
0.033298363 |
Sensitive |
| ENSG00000233237.2 |
Axitinib |
Lung squamous cell carcinoma |
0.043136202 |
Sensitive |
| ENSG00000233429.5 |
Axitinib |
Lung squamous cell carcinoma |
0.02047039 |
Sensitive |
| ENSG00000233627.2 |
Axitinib |
Lung squamous cell carcinoma |
0.046430889 |
Sensitive |
| ENSG00000234160.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002703639 |
Sensitive |
| ENSG00000234290.2 |
Axitinib |
Lung squamous cell carcinoma |
0.003271796 |
Sensitive |
| ENSG00000235033.3 |
Axitinib |
Lung squamous cell carcinoma |
0.025322872 |
Sensitive |
| ENSG00000235635.1 |
Axitinib |
Lung squamous cell carcinoma |
0.00404494 |
Sensitive |
| ENSG00000235872.2 |
Axitinib |
Lung squamous cell carcinoma |
0.045107356 |
Sensitive |
| ENSG00000236901.3 |
Axitinib |
Lung squamous cell carcinoma |
0.047484579 |
Sensitive |
| ENSG00000236983.1 |
Axitinib |
Lung squamous cell carcinoma |
0.017550002 |
Sensitive |
| ENSG00000237943.2 |
Axitinib |
Lung squamous cell carcinoma |
0.039015213 |
Sensitive |
| ENSG00000239774.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032862605 |
Sensitive |
| ENSG00000241180.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027953847 |
Sensitive |
| ENSG00000242686.2 |
Axitinib |
Lung squamous cell carcinoma |
0.033733225 |
Sensitive |
| ENSG00000244676.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049080794 |
Sensitive |
| ENSG00000248774.1 |
Axitinib |
Lung squamous cell carcinoma |
0.022069629 |
Sensitive |
| ENSG00000250432.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0227134 |
Sensitive |
| ENSG00000253121.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010041082 |
Sensitive |
| ENSG00000253347.1 |
Axitinib |
Lung squamous cell carcinoma |
0.029364514 |
Sensitive |
| ENSG00000253591.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0328963 |
Sensitive |
| ENSG00000253696.2 |
Axitinib |
Lung squamous cell carcinoma |
0.029058402 |
Sensitive |
| ENSG00000253764.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047040777 |
Sensitive |
| ENSG00000253878.1 |
Axitinib |
Lung squamous cell carcinoma |
0.040908682 |
Sensitive |
| ENSG00000254556.1 |
Axitinib |
Lung squamous cell carcinoma |
0.025061949 |
Sensitive |
| ENSG00000254592.1 |
Axitinib |
Lung squamous cell carcinoma |
0.047508591 |
Sensitive |
| ENSG00000254936.3 |
Axitinib |
Lung squamous cell carcinoma |
0.033358778 |
Sensitive |
| ENSG00000255310.2 |
Axitinib |
Lung squamous cell carcinoma |
0.025041015 |
Sensitive |
| ENSG00000257366.1 |
Axitinib |
Lung squamous cell carcinoma |
0.039476024 |
Sensitive |
| ENSG00000257391.1 |
Axitinib |
Lung squamous cell carcinoma |
0.031355589 |
Sensitive |
| ENSG00000257953.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049932648 |
Sensitive |
| ENSG00000259234.1 |
Axitinib |
Lung squamous cell carcinoma |
0.032156766 |
Sensitive |
| ENSG00000259396.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027857719 |
Sensitive |
| ENSG00000260388.1 |
Axitinib |
Lung squamous cell carcinoma |
0.009090349 |
Sensitive |
| ENSG00000260831.1 |
Axitinib |
Lung squamous cell carcinoma |
0.0359696 |
Sensitive |
| ENSG00000261096.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021640855 |
Sensitive |
| ENSG00000261338.1 |
Axitinib |
Lung squamous cell carcinoma |
0.029126892 |
Sensitive |
| ENSG00000263321.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027441157 |
Sensitive |
| ENSG00000263612.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049592104 |
Sensitive |
| ENSG00000263674.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027041433 |
Sensitive |
| ENSG00000264647.1 |
Axitinib |
Lung squamous cell carcinoma |
0.03197 |
Sensitive |
| ENSG00000265496.2 |
Axitinib |
Lung squamous cell carcinoma |
0.046272344 |
Sensitive |
| ENSG00000266111.1 |
Axitinib |
Lung squamous cell carcinoma |
0.027763884 |
Sensitive |
| ENSG00000266120.1 |
Axitinib |
Lung squamous cell carcinoma |
0.025767891 |
Sensitive |
| ENSG00000266935.1 |
Axitinib |
Lung squamous cell carcinoma |
0.024279824 |
Sensitive |
| ENSG00000267563.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046168347 |
Sensitive |
| ENSG00000267787.1 |
Axitinib |
Lung squamous cell carcinoma |
0.023406757 |
Sensitive |
| ENSG00000267919.1 |
Axitinib |
Lung squamous cell carcinoma |
0.044740319 |
Sensitive |
| ENSG00000269177.1 |
Axitinib |
Lung squamous cell carcinoma |
0.049896992 |
Sensitive |
| ENSG00000269694.1 |
Axitinib |
Lung squamous cell carcinoma |
0.016132324 |
Sensitive |
| ENSG00000269889.1 |
Axitinib |
Lung squamous cell carcinoma |
0.044991763 |
Sensitive |
| ENSG00000269918.1 |
Axitinib |
Lung squamous cell carcinoma |
0.012819698 |
Sensitive |
| ENSG00000270171.1 |
Axitinib |
Lung squamous cell carcinoma |
0.018369182 |
Sensitive |
| ENSG00000270173.1 |
Axitinib |
Lung squamous cell carcinoma |
0.046512595 |
Sensitive |
| ENSG00000270522.1 |
Axitinib |
Lung squamous cell carcinoma |
0.045888324 |
Sensitive |
| ENSG00000270988.1 |
Axitinib |
Lung squamous cell carcinoma |
0.015564459 |
Sensitive |
| ENSG00000271734.1 |
Axitinib |
Lung squamous cell carcinoma |
0.033965944 |
Sensitive |
| ENSG00000271803.1 |
Axitinib |
Lung squamous cell carcinoma |
0.026834661 |
Sensitive |
| ENSG00000271894.1 |
Axitinib |
Lung squamous cell carcinoma |
0.037115829 |
Sensitive |
| ENSG00000272180.1 |
Axitinib |
Lung squamous cell carcinoma |
0.042593467 |
Sensitive |
| ENSG00000272217.1 |
Axitinib |
Lung squamous cell carcinoma |
0.014184906 |
Sensitive |
| ENSG00000272308.1 |
Axitinib |
Lung squamous cell carcinoma |
0.002345888 |
Sensitive |
| ENSG00000272438.1 |
Axitinib |
Lung squamous cell carcinoma |
0.026434213 |
Sensitive |
| ENSG00000272452.1 |
Axitinib |
Lung squamous cell carcinoma |
0.007998689 |
Sensitive |
| ENSG00000272828.1 |
Axitinib |
Lung squamous cell carcinoma |
0.021531768 |
Sensitive |
| ENSG00000273373.1 |
Axitinib |
Lung squamous cell carcinoma |
0.026005134 |
Sensitive |
| ENSG00000273416.1 |
Axitinib |
Lung squamous cell carcinoma |
0.010020994 |
Sensitive |
| ENSG00000273476.1 |
Axitinib |
Lung squamous cell carcinoma |
0.024929479 |
Sensitive |
| ENSG00000172250.10 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032999293 |
Sensitive |
| ENSG00000198221.7 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018194033 |
Sensitive |
| ENSG00000223396.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034489164 |
Sensitive |
| ENSG00000224157.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038643061 |
Sensitive |
| ENSG00000225439.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028473929 |
Sensitive |
| ENSG00000225446.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023895767 |
Sensitive |
| ENSG00000227110.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02718981 |
Sensitive |
| ENSG00000227857.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04310384 |
Sensitive |
| ENSG00000229525.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023643169 |
Sensitive |
| ENSG00000233862.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012690953 |
Sensitive |
| ENSG00000234181.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042192602 |
Sensitive |
| ENSG00000234869.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034391976 |
Sensitive |
| ENSG00000235590.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016291728 |
Sensitive |
| ENSG00000236137.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024241695 |
Sensitive |
| ENSG00000237609.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002223617 |
Sensitive |
| ENSG00000248222.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03141687 |
Sensitive |
| ENSG00000250061.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022351781 |
Sensitive |
| ENSG00000251365.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047708211 |
Sensitive |
| ENSG00000251615.3 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022317356 |
Sensitive |
| ENSG00000255689.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046971839 |
Sensitive |
| ENSG00000255989.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005566063 |
Sensitive |
| ENSG00000259138.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03587188 |
Sensitive |
| ENSG00000259349.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03106639 |
Sensitive |
| ENSG00000259687.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01753839 |
Sensitive |
| ENSG00000260086.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048776387 |
Sensitive |
| ENSG00000260248.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026050366 |
Sensitive |
| ENSG00000260278.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009305386 |
Sensitive |
| ENSG00000261183.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039687695 |
Sensitive |
| ENSG00000261798.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004542389 |
Sensitive |
| ENSG00000262147.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038871488 |
Sensitive |
| ENSG00000265185.2 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047647646 |
Sensitive |
| ENSG00000267786.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044636772 |
Sensitive |
| ENSG00000272023.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030305456 |
Sensitive |
| ENSG00000272368.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043056374 |
Sensitive |
| ENSG00000272384.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040388463 |
Sensitive |
| ENSG00000272583.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00353568 |
Sensitive |
| ENSG00000272610.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011945023 |
Sensitive |
| ENSG00000273026.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033438445 |
Sensitive |
| ENSG00000273061.1 |
Axitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034666126 |
Sensitive |
| ENSG00000172250.10 |
Axitinib |
Pancreatic adenocarcinoma |
0.006139041 |
Sensitive |
| ENSG00000179219.5 |
Axitinib |
Pancreatic adenocarcinoma |
0.004042678 |
Sensitive |
| ENSG00000180279.5 |
Axitinib |
Pancreatic adenocarcinoma |
0.017063065 |
Sensitive |
| ENSG00000182109.3 |
Axitinib |
Pancreatic adenocarcinoma |
0.015421775 |
Sensitive |
| ENSG00000182376.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.006947079 |
Sensitive |
| ENSG00000206140.5 |
Axitinib |
Pancreatic adenocarcinoma |
0.001527604 |
Sensitive |
| ENSG00000211683.3 |
Axitinib |
Pancreatic adenocarcinoma |
0.03086196 |
Sensitive |
| ENSG00000223635.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.027230783 |
Sensitive |
| ENSG00000224699.4 |
Axitinib |
Pancreatic adenocarcinoma |
0.033448782 |
Sensitive |
| ENSG00000225177.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.022535695 |
Sensitive |
| ENSG00000225213.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.004143359 |
Sensitive |
| ENSG00000225235.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.026882626 |
Sensitive |
| ENSG00000225914.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.020031273 |
Sensitive |
| ENSG00000226900.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.018510075 |
Sensitive |
| ENSG00000227704.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.003321383 |
Sensitive |
| ENSG00000227888.3 |
Axitinib |
Pancreatic adenocarcinoma |
0.026812636 |
Sensitive |
| ENSG00000228962.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.028886381 |
Sensitive |
| ENSG00000228989.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.017097128 |
Sensitive |
| ENSG00000229203.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.014096189 |
Sensitive |
| ENSG00000229393.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.016364974 |
Sensitive |
| ENSG00000229905.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.038524677 |
Sensitive |
| ENSG00000230074.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.00380511 |
Sensitive |
| ENSG00000230148.4 |
Axitinib |
Pancreatic adenocarcinoma |
0.000846496 |
Sensitive |
| ENSG00000230319.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.01329463 |
Sensitive |
| ENSG00000230736.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.036244785 |
Sensitive |
| ENSG00000231305.3 |
Axitinib |
Pancreatic adenocarcinoma |
0.021307259 |
Sensitive |
| ENSG00000231628.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.041352756 |
Sensitive |
| ENSG00000233411.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.009411505 |
Sensitive |
| ENSG00000234199.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.04597963 |
Sensitive |
| ENSG00000234753.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.048424821 |
Sensitive |
| ENSG00000234917.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.009821654 |
Sensitive |
| ENSG00000235106.4 |
Axitinib |
Pancreatic adenocarcinoma |
0.011407472 |
Sensitive |
| ENSG00000236140.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.031815302 |
Sensitive |
| ENSG00000236144.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.029002258 |
Sensitive |
| ENSG00000237133.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.026349451 |
Sensitive |
| ENSG00000239498.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.012171384 |
Sensitive |
| ENSG00000241570.4 |
Axitinib |
Pancreatic adenocarcinoma |
0.018627086 |
Sensitive |
| ENSG00000242154.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.009875641 |
Sensitive |
| ENSG00000243055.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.005257611 |
Sensitive |
| ENSG00000247228.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.01263292 |
Sensitive |
| ENSG00000249356.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.005268855 |
Sensitive |
| ENSG00000250107.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.027012001 |
Sensitive |
| ENSG00000251604.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.043202658 |
Sensitive |
| ENSG00000253829.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.028887121 |
Sensitive |
| ENSG00000254756.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.01949039 |
Sensitive |
| ENSG00000254872.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.005952741 |
Sensitive |
| ENSG00000255020.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.002391044 |
Sensitive |
| ENSG00000255471.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.047739508 |
Sensitive |
| ENSG00000258857.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.045731403 |
Sensitive |
| ENSG00000258920.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.011468404 |
Sensitive |
| ENSG00000259306.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.042366905 |
Sensitive |
| ENSG00000259476.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.000673504 |
Sensitive |
| ENSG00000259520.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.002369221 |
Sensitive |
| ENSG00000259623.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.00661629 |
Sensitive |
| ENSG00000259802.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.043862698 |
Sensitive |
| ENSG00000259994.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.029044775 |
Sensitive |
| ENSG00000260645.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.013394921 |
Sensitive |
| ENSG00000260646.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.047978367 |
Sensitive |
| ENSG00000260743.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.038752789 |
Sensitive |
| ENSG00000260837.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.043699893 |
Sensitive |
| ENSG00000260891.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.035973761 |
Sensitive |
| ENSG00000260948.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.020944281 |
Sensitive |
| ENSG00000261252.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.020556473 |
Sensitive |
| ENSG00000261433.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.021468697 |
Sensitive |
| ENSG00000261474.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.03048226 |
Sensitive |
| ENSG00000261589.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.016159557 |
Sensitive |
| ENSG00000261770.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.029381057 |
Sensitive |
| ENSG00000262619.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.01965681 |
Sensitive |
| ENSG00000262873.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.008643634 |
Sensitive |
| ENSG00000263050.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.013314699 |
Sensitive |
| ENSG00000263164.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.049069116 |
Sensitive |
| ENSG00000263350.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.009130788 |
Sensitive |
| ENSG00000264647.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.046940767 |
Sensitive |
| ENSG00000266411.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.043387899 |
Sensitive |
| ENSG00000266916.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.004726791 |
Sensitive |
| ENSG00000266930.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.027122763 |
Sensitive |
| ENSG00000267053.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.004803832 |
Sensitive |
| ENSG00000267143.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.037774781 |
Sensitive |
| ENSG00000267199.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.017217979 |
Sensitive |
| ENSG00000267249.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.022711542 |
Sensitive |
| ENSG00000267296.2 |
Axitinib |
Pancreatic adenocarcinoma |
0.005932645 |
Sensitive |
| ENSG00000267397.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.019005926 |
Sensitive |
| ENSG00000268006.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.040853998 |
Sensitive |
| ENSG00000268230.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.036366648 |
Sensitive |
| ENSG00000268262.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.040849397 |
Sensitive |
| ENSG00000268340.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.015076168 |
Sensitive |
| ENSG00000268375.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.031921424 |
Sensitive |
| ENSG00000268388.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.023874355 |
Sensitive |
| ENSG00000268836.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.035705566 |
Sensitive |
| ENSG00000269560.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.003728913 |
Sensitive |
| ENSG00000269834.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.007788205 |
Sensitive |
| ENSG00000269949.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.031815396 |
Sensitive |
| ENSG00000270081.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.004997267 |
Sensitive |
| ENSG00000270102.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.007198583 |
Sensitive |
| ENSG00000270949.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.025827773 |
Sensitive |
| ENSG00000271384.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.025589707 |
Sensitive |
| ENSG00000271992.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.026731599 |
Sensitive |
| ENSG00000272010.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.031252358 |
Sensitive |
| ENSG00000272048.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.012469152 |
Sensitive |
| ENSG00000272161.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.04551005 |
Sensitive |
| ENSG00000272375.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.046343764 |
Sensitive |
| ENSG00000272520.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.035517969 |
Sensitive |
| ENSG00000272567.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.021094444 |
Sensitive |
| ENSG00000272622.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.024702281 |
Sensitive |
| ENSG00000272682.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.009385157 |
Sensitive |
| ENSG00000272702.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.016176455 |
Sensitive |
| ENSG00000272733.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.0013741 |
Sensitive |
| ENSG00000272828.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.019055164 |
Sensitive |
| ENSG00000273027.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.012838548 |
Sensitive |
| ENSG00000273125.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.021564537 |
Sensitive |
| ENSG00000273164.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.042238616 |
Sensitive |
| ENSG00000273190.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.011992443 |
Sensitive |
| ENSG00000273290.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.046894389 |
Sensitive |
| ENSG00000273342.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.015660188 |
Sensitive |
| ENSG00000273355.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.0000476 |
Sensitive |
| ENSG00000273416.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.048861326 |
Sensitive |
| ENSG00000273483.1 |
Axitinib |
Pancreatic adenocarcinoma |
0.037538909 |
Sensitive |
| ENSG00000135253.9 |
Axitinib |
Sarcoma |
0.043923792 |
Sensitive |
| ENSG00000174680.5 |
Axitinib |
Sarcoma |
0.000375992 |
Sensitive |
| ENSG00000178947.8 |
Axitinib |
Sarcoma |
0.040532127 |
Sensitive |
| ENSG00000185203.7 |
Axitinib |
Sarcoma |
0.01654678 |
Sensitive |
| ENSG00000217576.7 |
Axitinib |
Sarcoma |
0.004522352 |
Sensitive |
| ENSG00000223573.2 |
Axitinib |
Sarcoma |
0.007826211 |
Sensitive |
| ENSG00000225039.1 |
Axitinib |
Sarcoma |
0.020529333 |
Sensitive |
| ENSG00000226386.1 |
Axitinib |
Sarcoma |
0.030721715 |
Sensitive |
| ENSG00000226904.1 |
Axitinib |
Sarcoma |
0.008260049 |
Sensitive |
| ENSG00000227373.1 |
Axitinib |
Sarcoma |
0.003906255 |
Sensitive |
| ENSG00000227486.1 |
Axitinib |
Sarcoma |
0.027858862 |
Sensitive |
| ENSG00000228393.3 |
Axitinib |
Sarcoma |
0.034243632 |
Sensitive |
| ENSG00000228962.1 |
Axitinib |
Sarcoma |
0.001613885 |
Sensitive |
| ENSG00000229356.1 |
Axitinib |
Sarcoma |
0.012429118 |
Sensitive |
| ENSG00000230506.1 |
Axitinib |
Sarcoma |
0.010776912 |
Sensitive |
| ENSG00000231439.3 |
Axitinib |
Sarcoma |
0.010161208 |
Sensitive |
| ENSG00000231636.1 |
Axitinib |
Sarcoma |
0.02544546 |
Sensitive |
| ENSG00000232470.1 |
Axitinib |
Sarcoma |
0.012428028 |
Sensitive |
| ENSG00000233483.2 |
Axitinib |
Sarcoma |
0.04973417 |
Sensitive |
| ENSG00000234230.1 |
Axitinib |
Sarcoma |
0.017050978 |
Sensitive |
| ENSG00000234698.1 |
Axitinib |
Sarcoma |
0.025021157 |
Sensitive |
| ENSG00000235501.1 |
Axitinib |
Sarcoma |
0.011590392 |
Sensitive |
| ENSG00000236426.3 |
Axitinib |
Sarcoma |
0.03039211 |
Sensitive |
| ENSG00000237461.1 |
Axitinib |
Sarcoma |
0.027304635 |
Sensitive |
| ENSG00000237836.1 |
Axitinib |
Sarcoma |
0.037103068 |
Sensitive |
| ENSG00000241288.3 |
Axitinib |
Sarcoma |
0.0387762 |
Sensitive |
| ENSG00000245556.2 |
Axitinib |
Sarcoma |
0.024901902 |
Sensitive |
| ENSG00000246582.2 |
Axitinib |
Sarcoma |
0.038962528 |
Sensitive |
| ENSG00000248468.1 |
Axitinib |
Sarcoma |
0.013422916 |
Sensitive |
| ENSG00000249359.2 |
Axitinib |
Sarcoma |
0.00716338 |
Sensitive |
| ENSG00000249650.1 |
Axitinib |
Sarcoma |
0.038673713 |
Sensitive |
| ENSG00000249786.3 |
Axitinib |
Sarcoma |
0.010540249 |
Sensitive |
| ENSG00000250714.3 |
Axitinib |
Sarcoma |
0.032476552 |
Sensitive |
| ENSG00000254604.1 |
Axitinib |
Sarcoma |
0.0272878 |
Sensitive |
| ENSG00000254855.1 |
Axitinib |
Sarcoma |
0.011129176 |
Sensitive |
| ENSG00000255326.1 |
Axitinib |
Sarcoma |
0.049890022 |
Sensitive |
| ENSG00000255571.2 |
Axitinib |
Sarcoma |
0.002581495 |
Sensitive |
| ENSG00000257058.1 |
Axitinib |
Sarcoma |
0.01910388 |
Sensitive |
| ENSG00000258122.1 |
Axitinib |
Sarcoma |
0.001604507 |
Sensitive |
| ENSG00000259319.1 |
Axitinib |
Sarcoma |
0.025511518 |
Sensitive |
| ENSG00000259774.1 |
Axitinib |
Sarcoma |
0.001704206 |
Sensitive |
| ENSG00000259959.1 |
Axitinib |
Sarcoma |
0.03414466 |
Sensitive |
| ENSG00000260493.1 |
Axitinib |
Sarcoma |
0.030131356 |
Sensitive |
| ENSG00000260792.1 |
Axitinib |
Sarcoma |
0.021394912 |
Sensitive |
| ENSG00000260912.1 |
Axitinib |
Sarcoma |
0.002158496 |
Sensitive |
| ENSG00000261015.1 |
Axitinib |
Sarcoma |
0.001227819 |
Sensitive |
| ENSG00000261373.1 |
Axitinib |
Sarcoma |
0.03350307 |
Sensitive |
| ENSG00000261438.1 |
Axitinib |
Sarcoma |
0.014062632 |
Sensitive |
| ENSG00000262772.1 |
Axitinib |
Sarcoma |
0.003620435 |
Sensitive |
| ENSG00000262873.1 |
Axitinib |
Sarcoma |
0.000379434 |
Sensitive |
| ENSG00000263680.2 |
Axitinib |
Sarcoma |
0.047143718 |
Sensitive |
| ENSG00000266473.1 |
Axitinib |
Sarcoma |
0.030006836 |
Sensitive |
| ENSG00000266538.1 |
Axitinib |
Sarcoma |
0.000928229 |
Sensitive |
| ENSG00000269486.1 |
Axitinib |
Sarcoma |
0.031414662 |
Sensitive |
| ENSG00000269609.1 |
Axitinib |
Sarcoma |
0.010337066 |
Sensitive |
| ENSG00000270761.1 |
Axitinib |
Sarcoma |
0.033786917 |
Sensitive |
| ENSG00000271727.1 |
Axitinib |
Sarcoma |
0.000499558 |
Sensitive |
| ENSG00000271967.1 |
Axitinib |
Sarcoma |
0.043189609 |
Sensitive |
| ENSG00000272156.1 |
Axitinib |
Sarcoma |
0.012763083 |
Sensitive |
| ENSG00000272327.1 |
Axitinib |
Sarcoma |
0.017541354 |
Sensitive |
| ENSG00000273183.1 |
Axitinib |
Sarcoma |
0.041537411 |
Sensitive |
| ENSG00000273352.1 |
Axitinib |
Sarcoma |
0.018046055 |
Sensitive |
| ENSG00000117242.7 |
Axitinib |
Skin cutaneous melanoma |
0.037899502 |
Sensitive |
| ENSG00000203364.2 |
Axitinib |
Skin cutaneous melanoma |
0.036812157 |
Sensitive |
| ENSG00000214559.3 |
Axitinib |
Skin cutaneous melanoma |
0.041172909 |
Sensitive |
| ENSG00000223855.1 |
Axitinib |
Skin cutaneous melanoma |
0.03781042 |
Sensitive |
| ENSG00000224660.1 |
Axitinib |
Skin cutaneous melanoma |
0.040671713 |
Sensitive |
| ENSG00000224715.1 |
Axitinib |
Skin cutaneous melanoma |
0.048621572 |
Sensitive |
| ENSG00000225393.1 |
Axitinib |
Skin cutaneous melanoma |
0.024466596 |
Sensitive |
| ENSG00000225684.3 |
Axitinib |
Skin cutaneous melanoma |
0.01519924 |
Sensitive |
| ENSG00000225969.1 |
Axitinib |
Skin cutaneous melanoma |
0.041558064 |
Sensitive |
| ENSG00000226472.3 |
Axitinib |
Skin cutaneous melanoma |
0.013664842 |
Sensitive |
| ENSG00000226819.1 |
Axitinib |
Skin cutaneous melanoma |
0.006251288 |
Sensitive |
| ENSG00000227496.1 |
Axitinib |
Skin cutaneous melanoma |
0.02504846 |
Sensitive |
| ENSG00000227681.1 |
Axitinib |
Skin cutaneous melanoma |
0.008913176 |
Sensitive |
| ENSG00000228141.2 |
Axitinib |
Skin cutaneous melanoma |
0.046899657 |
Sensitive |
| ENSG00000228486.5 |
Axitinib |
Skin cutaneous melanoma |
0.026591409 |
Sensitive |
| ENSG00000228817.3 |
Axitinib |
Skin cutaneous melanoma |
0.024475932 |
Sensitive |
| ENSG00000229291.1 |
Axitinib |
Skin cutaneous melanoma |
0.003630406 |
Sensitive |
| ENSG00000229563.2 |
Axitinib |
Skin cutaneous melanoma |
0.031259849 |
Sensitive |
| ENSG00000229869.1 |
Axitinib |
Skin cutaneous melanoma |
0.041567806 |
Sensitive |
| ENSG00000230058.1 |
Axitinib |
Skin cutaneous melanoma |
0.015643174 |
Sensitive |
| ENSG00000230176.2 |
Axitinib |
Skin cutaneous melanoma |
0.024398356 |
Sensitive |
| ENSG00000230303.1 |
Axitinib |
Skin cutaneous melanoma |
0.027479192 |
Sensitive |
| ENSG00000230613.1 |
Axitinib |
Skin cutaneous melanoma |
0.00419528 |
Sensitive |
| ENSG00000231010.1 |
Axitinib |
Skin cutaneous melanoma |
0.04964478 |
Sensitive |
| ENSG00000231528.2 |
Axitinib |
Skin cutaneous melanoma |
0.014911143 |
Sensitive |
| ENSG00000232693.2 |
Axitinib |
Skin cutaneous melanoma |
0.039427953 |
Sensitive |
| ENSG00000234478.1 |
Axitinib |
Skin cutaneous melanoma |
0.00292761 |
Sensitive |
| ENSG00000234617.1 |
Axitinib |
Skin cutaneous melanoma |
0.02918109 |
Sensitive |
| ENSG00000234807.4 |
Axitinib |
Skin cutaneous melanoma |
0.02053735 |
Sensitive |
| ENSG00000236472.1 |
Axitinib |
Skin cutaneous melanoma |
0.021501966 |
Sensitive |
| ENSG00000236520.2 |
Axitinib |
Skin cutaneous melanoma |
0.036093915 |
Sensitive |
| ENSG00000236581.4 |
Axitinib |
Skin cutaneous melanoma |
0.000482275 |
Sensitive |
| ENSG00000237461.1 |
Axitinib |
Skin cutaneous melanoma |
0.036095323 |
Sensitive |
| ENSG00000237807.3 |
Axitinib |
Skin cutaneous melanoma |
0.007305024 |
Sensitive |
| ENSG00000238273.3 |
Axitinib |
Skin cutaneous melanoma |
0.028961167 |
Sensitive |
| ENSG00000238279.1 |
Axitinib |
Skin cutaneous melanoma |
0.000314796 |
Sensitive |
| ENSG00000239462.1 |
Axitinib |
Skin cutaneous melanoma |
0.037939192 |
Sensitive |
| ENSG00000239705.1 |
Axitinib |
Skin cutaneous melanoma |
0.019004772 |
Sensitive |
| ENSG00000240143.1 |
Axitinib |
Skin cutaneous melanoma |
0.007111464 |
Sensitive |
| ENSG00000240254.1 |
Axitinib |
Skin cutaneous melanoma |
0.02060983 |
Sensitive |
| ENSG00000240350.1 |
Axitinib |
Skin cutaneous melanoma |
0.00937912 |
Sensitive |
| ENSG00000240476.1 |
Axitinib |
Skin cutaneous melanoma |
0.042283371 |
Sensitive |
| ENSG00000241684.1 |
Axitinib |
Skin cutaneous melanoma |
0.019715129 |
Sensitive |
| ENSG00000242861.1 |
Axitinib |
Skin cutaneous melanoma |
0.040440246 |
Sensitive |
| ENSG00000245479.2 |
Axitinib |
Skin cutaneous melanoma |
0.040858124 |
Sensitive |
| ENSG00000248461.1 |
Axitinib |
Skin cutaneous melanoma |
0.034046138 |
Sensitive |
| ENSG00000248647.2 |
Axitinib |
Skin cutaneous melanoma |
0.0000776 |
Sensitive |
| ENSG00000250303.2 |
Axitinib |
Skin cutaneous melanoma |
0.026148526 |
Sensitive |
| ENSG00000250548.2 |
Axitinib |
Skin cutaneous melanoma |
0.016010047 |
Sensitive |
| ENSG00000251194.2 |
Axitinib |
Skin cutaneous melanoma |
0.023016668 |
Sensitive |
| ENSG00000253408.1 |
Axitinib |
Skin cutaneous melanoma |
0.009309492 |
Sensitive |
| ENSG00000254204.1 |
Axitinib |
Skin cutaneous melanoma |
0.007730738 |
Sensitive |
| ENSG00000256690.1 |
Axitinib |
Skin cutaneous melanoma |
0.04811392 |
Sensitive |
| ENSG00000257910.1 |
Axitinib |
Skin cutaneous melanoma |
0.021330089 |
Sensitive |
| ENSG00000258413.1 |
Axitinib |
Skin cutaneous melanoma |
0.0000639 |
Sensitive |
| ENSG00000260065.1 |
Axitinib |
Skin cutaneous melanoma |
0.044425401 |
Sensitive |
| ENSG00000260101.1 |
Axitinib |
Skin cutaneous melanoma |
0.04095098 |
Sensitive |
| ENSG00000260895.1 |
Axitinib |
Skin cutaneous melanoma |
0.025795962 |
Sensitive |
| ENSG00000260911.1 |
Axitinib |
Skin cutaneous melanoma |
0.029863509 |
Sensitive |
| ENSG00000261342.1 |
Axitinib |
Skin cutaneous melanoma |
0.046080529 |
Sensitive |
| ENSG00000261616.1 |
Axitinib |
Skin cutaneous melanoma |
0.038869525 |
Sensitive |
| ENSG00000261924.1 |
Axitinib |
Skin cutaneous melanoma |
0.024132517 |
Sensitive |
| ENSG00000262585.1 |
Axitinib |
Skin cutaneous melanoma |
0.017315545 |
Sensitive |
| ENSG00000262721.1 |
Axitinib |
Skin cutaneous melanoma |
0.027298135 |
Sensitive |
| ENSG00000264269.1 |
Axitinib |
Skin cutaneous melanoma |
0.026882128 |
Sensitive |
| ENSG00000264673.1 |
Axitinib |
Skin cutaneous melanoma |
0.014267269 |
Sensitive |
| ENSG00000267304.1 |
Axitinib |
Skin cutaneous melanoma |
0.004984473 |
Sensitive |
| ENSG00000267919.1 |
Axitinib |
Skin cutaneous melanoma |
0.02208017 |
Sensitive |
| ENSG00000268199.2 |
Axitinib |
Skin cutaneous melanoma |
0.011610963 |
Sensitive |
| ENSG00000270141.2 |
Axitinib |
Skin cutaneous melanoma |
0.039224607 |
Sensitive |
| ENSG00000271344.1 |
Axitinib |
Skin cutaneous melanoma |
0.022928114 |
Sensitive |
| ENSG00000272695.1 |
Axitinib |
Skin cutaneous melanoma |
0.018954812 |
Sensitive |
| ENSG00000272734.1 |
Axitinib |
Skin cutaneous melanoma |
0.023254761 |
Sensitive |
| ENSG00000273032.1 |
Axitinib |
Skin cutaneous melanoma |
0.030486408 |
Sensitive |
| ENSG00000273038.1 |
Axitinib |
Skin cutaneous melanoma |
0.03229177 |
Sensitive |
| ENSG00000273174.1 |
Axitinib |
Skin cutaneous melanoma |
0.028042432 |
Sensitive |
